
<html lang="en"     class="pb-page"  data-request-id="d105191f-0e80-49c2-a488-95ec2445d711"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm201394e;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT" /></meta><meta name="dc.Creator" content="Jason G.  Kettle" /></meta><meta name="dc.Creator" content="Simon  Brown" /></meta><meta name="dc.Creator" content="Claire  Crafter" /></meta><meta name="dc.Creator" content="Barry R.  Davies" /></meta><meta name="dc.Creator" content="Phillippa  Dudley" /></meta><meta name="dc.Creator" content="Gary  Fairley" /></meta><meta name="dc.Creator" content="Paul  Faulder" /></meta><meta name="dc.Creator" content="Shaun  Fillery" /></meta><meta name="dc.Creator" content="Hannah  Greenwood" /></meta><meta name="dc.Creator" content="Janet  Hawkins" /></meta><meta name="dc.Creator" content="Michael  James" /></meta><meta name="dc.Creator" content="Keith  Johnson" /></meta><meta name="dc.Creator" content="Clare D.  Lane" /></meta><meta name="dc.Creator" content="Martin  Pass" /></meta><meta name="dc.Creator" content="Jennifer H.  Pink" /></meta><meta name="dc.Creator" content="Helen  Plant" /></meta><meta name="dc.Creator" content="Sabina C.  Cosulich" /></meta><meta name="dc.Description" content="Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and ph..." /></meta><meta name="Description" content="Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and ph..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 27, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201394e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201394e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201394e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201394e" /></link>
        
    
    

<title>Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201394e" /></meta><meta property="og:title" content="Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0017.jpeg" /></meta><meta property="og:description" content="Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201394e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201394e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201394e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201394e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201394e&amp;href=/doi/10.1021/jm201394e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1261-1273</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201388p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201422e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+G.++Kettle">Jason G. Kettle</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Brown">Simon Brown</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Crafter">Claire Crafter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+R.++Davies">Barry R. Davies</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Phillippa++Dudley">Phillippa Dudley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Fairley">Gary Fairley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Faulder">Paul Faulder</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shaun++Fillery">Shaun Fillery</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hannah++Greenwood">Hannah Greenwood</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janet++Hawkins">Janet Hawkins</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++James">Michael James</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Johnson">Keith Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clare+D.++Lane">Clare D. Lane</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Pass">Martin Pass</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+H.++Pink">Jennifer H. Pink</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helen++Plant">Helen Plant</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabina+C.++Cosulich">Sabina C. Cosulich</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Tel: +441625 517920. E-mail: <a href="/cdn-cgi/l/email-protection#355f54465a5b1b5e50414159507554464147544f505b5056541b565a58"><span class="__cf_email__" data-cfemail="2d474c5e4243034648595941486d4c5e595f4c574843484e4c034e4240">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201394e&amp;href=/doi/10.1021%2Fjm201394e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1261–1273</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 16, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 October 2011</li><li><span class="item_label"><b>Published</b> online</span>27 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201394e" title="DOI URL">https://doi.org/10.1021/jm201394e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1261%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJason%2BG.%2BKettle%252C%2BSimon%2BBrown%252C%2BClaire%2BCrafter%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D3%26contentID%3Djm201394e%26title%3DDiverse%2BHeterocyclic%2BScaffolds%2Bas%2BAllosteric%2BInhibitors%2Bof%2BAKT%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1273%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201394e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3611</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201394e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;G. Kettle&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Crafter&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;R. Davies&quot;},{&quot;first_name&quot;:&quot;Phillippa&quot;,&quot;last_name&quot;:&quot;Dudley&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Fairley&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Faulder&quot;},{&quot;first_name&quot;:&quot;Shaun&quot;,&quot;last_name&quot;:&quot;Fillery&quot;},{&quot;first_name&quot;:&quot;Hannah&quot;,&quot;last_name&quot;:&quot;Greenwood&quot;},{&quot;first_name&quot;:&quot;Janet&quot;,&quot;last_name&quot;:&quot;Hawkins&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;James&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Clare&quot;,&quot;last_name&quot;:&quot;D. Lane&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Pass&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;H. Pink&quot;},{&quot;first_name&quot;:&quot;Helen&quot;,&quot;last_name&quot;:&quot;Plant&quot;},{&quot;first_name&quot;:&quot;Sabina&quot;,&quot;last_name&quot;:&quot;C. Cosulich&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1261-1273&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201394e&quot;},&quot;abstract&quot;:&quot;Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201394e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201394e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201394e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201394e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201394e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201394e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201394e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201394e&amp;href=/doi/10.1021/jm201394e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201394e" /></input><a href="/doi/pdf/10.1021/jm201394e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201394e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201394e%26sid%3Dliteratum%253Aachs%26pmid%3D22248236%26genre%3Darticle%26aulast%3DKettle%26date%3D2012%26atitle%3DDiverse%2BHeterocyclic%2BScaffolds%2Bas%2BAllosteric%2BInhibitors%2Bof%2BAKT%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D3%26spage%3D1261%26epage%3D1273%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jmcmar.2012.55.issue-3/production/jmcmar.2012.55.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The PI3K-AKT signaling pathway is frequently activated in human cancers and plays a critical role in cell growth, proliferation, motility, and survival.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This pathway is activated by several mechanisms in different cancer types, including somatic mutation, deletion, and amplification of genes encoding key components. Because of its prominent role in many cancer types, the PI3K-AKT pathway has become the focus of many cancer therapies, with a number of compounds currently in early clinical trials.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Despite the significant efforts invested in the generation of inhibitors of components of this pathway, it remains unclear which cancers will benefit from such therapeutic approaches. The serine threonine kinase AKT (also known as protein kinase B or PKB) is a key effector of the PI3K-AKT signaling pathway and plays a pivotal role in cell survival and proliferation through modulation of a large number of downstream substrates.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Following growth factor stimulation of PI3K, AKT is recruited to the plasma membrane. Colocalization with PDK1 at the plasma membrane allows the phosphorylation of threonine 308 (Thr308), located in the AKT activation loop. This phosphorylation event is necessary and sufficient for AKT activation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Further phosphorylation of AKT on serine 473 (Ser473), located in the C-terminal hydrophobic motif by the mTOR complex 2,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> allows for maximal activation of the AKT enzyme.</div><div class="NLM_p">There are three mammalian isoforms of AKT (AKT1, -2, and -3) that are broadly expressed in most normal tissues and are also expressed in most tumor types to varying degrees. The three enzymes have a similar organizational structure: an N-terminal PH domain, a central serine/threonine catalytic domain, and a short regulatory region at the C-terminal, also called the hydrophobic motif.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> On the basis of the strong rationale for targeting AKT in cancer, many efforts have been made to identify AKT inhibitors with acceptable pharmaceutical properties. However, because of the high sequence identity between the different AKT isoforms and other AGC kinases, the development of AKT-specific and isoform-specific inhibitors has been a real challenge for the pharmaceutical industry. The most common approaches described to date have been either through the design of compounds that are ATP-competitive or prevent the formation of the active enzyme.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Inhibitors targeting the PH domain have also been described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> AKT inhibitors that are ATP competitive paradoxically cause the hyperphosphorylation of AKT at its two main regulatory sites (Thr308 and Ser473) as a consequence of a disrupted feedback mechanism caused by the direct binding of the inhibitor to the kinase.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In contrast, allosteric inhibitors cause a decrease in the phosphorylation of AKT at these two sites. The clinical significance of these findings is still unclear, with a number of AKT inhibitors currently being tested in clinical trials. These include allosteric inhibitors of inactive AKT, such as MK-2206 (<b>1</b>),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and ATP-competitive inhibitors of active enzyme, such as GDC0068 (<b>2</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> GSK2141795,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and AZD5363 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> It will be important to establish whether the different modes of inhibition of AKT will deliver efficacy in late-stage clinical trials. In order to compliment our own work with AZD5363, we were interested in exploring additional opportunities around an allosteric inhibitor of inactive AKT profile such as that described for <b>1</b>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Allosteric inhibitor of inactive AKT, MK-2206 (<b>1</b>), and an example of an inhibitor of active AKT, GDC-0068 (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design of Inhibitors</h3><div class="NLM_p">At the outset of this work, since the binding mode of <b>1</b> had not yet been reported, it was unclear which elements of the structure were critical for binding to AKT. Analysis of the extensive literature<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> of this series did however give an indication of which groups had been successfully varied and those which had largely been held constant, which was suggestive of an absolute basic pharmacophore. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> illustrates assumptions about the general requirements for binding based on published literature, together with our proposed strategy for optimization based on exploration of scaffolds outside of the perceived basic pharmacophore. The central scaffolds in the published SAR (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, left panel), often groups such as pyridine or quinoline, always retain an sp<sup>2</sup> nitrogen atom, which suggested a potential role in hydrogen bonding to AKT. Subsequent to this work, the first reported crystal structure of a compound related to <b>1</b> bound to AKT has been disclosed.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> While this structure confirms binding of inhibitor to the PH domain and C- and N-terminal lobes of the inactive kinase, no such hydrogen bond is observed, however. The scaffold itself can be extended in a number of ways, with examples of mono-, bi-, and tricyclic ring systems all reported. The lower pendant phenyl ring in all iterations remains unsubstituted, suggesting a relatively small lipophilic pocket in this region, and indeed, the related crystal structure shows this to be the case. A basic benzylic amine functionality appended to the upper phenyl ring is a common feature, although examples indicate that a wide variety of cyclic amines are tolerated, including those with relatively large overall size. The later reported structure indicated that this basic group is involved in a critical water-mediated hydrogen bond to asparagine 54 (Asn54) on the PH domain. The proposed strategy to investigate alternative core structures that would, it was hoped, provide novel scaffolds able to potently inhibit AKT can be broken down into several related themes. First, we wished to explore linear structures in which one ring junction contained a bridgehead nitrogen atom (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, right panel). Such a strategy has previously been successful in generating alternative scaffolds of quinazoline for inhibition of a variety of protein kinases,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and indeed, independent of this work, a group at Bayer has recently reported success with this strategy against AKT.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, we wished to explore opportunities for alternatively fused rings, here termed ring fusion “south” or “north”, dependent on the direction of the scaffold. Such changes have not been described previously, and it should be noted that for ring fusion north such an approach necessarily removes what we (at the time) perceived to be a critical sp<sup>2</sup> nitrogen atom. Nevertheless, it was felt that introduction of nitrogen into the resulting five-membered ring might be able to compensate for this loss, if some flexibility in nitrogen lone pair orientation might be tolerated. Finally, we explored a small number of additional novel scaffolds that were shown to be both synthetically accessible and novel, with energy-minimized conformations of all ideas proposed overlaid with those of the working pharmacophore to ensure consistency.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR for allosteric inhibition of AKT based on published data (left panel) and strategy for optimization to give novel cores (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>1</b> represents a highly optimized candidate drug. In order to be able to benchmark the utility of any novel scaffolds synthesized, it was important to use a suitable reference compound of similar size rather than <b>1</b> itself. The primary goal was to understand which, if any, novel scaffold could offer a platform for AKT inhibition, with further optimization of any scaffold reserved for subsequent studies. In the event, we selected compound <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) to act as the reference since quinoline is the simplest of the literature-validated bicyclic scaffolds. Although compound <b>3</b> has not previously been reported, the quinoline core has been described with a variety of alternative, extended amines in place of the cyclobutylamine moiety present in <b>1</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Reference compound <b>3</b> is able to potently inhibit phosphorylation of AKT in cells at both Thr308 and Ser473, consistent with its mechanism of action, with IC<sub>50</sub>’s of 0.557 and 0.250 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Enzyme activity was routinely assayed for all analogues synthesized. It should be noted, however, that the enzymatic assay utilized here was one using active enzyme, designed specifically for the purpose of testing inhibitors of catalysis, rather than, compounds that bind to and stabilize inactive enzyme. Nevertheless, such an assay is able to pick up activity via both modes of inhibition—the quoted activity is therefore an underestimate of the true level of potency—and generally cell activity was used to monitor chemistry progress. Compound <b>3</b> demonstrates a moderately high lipophilicity (log <i>D</i> = 3.6), and consequently low free drug (1.1% free drug measured in Han Wistar rat plasma) and a modest solubility of 290 μM.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Synthesis of AKT Inhibitors</h3><div class="NLM_p">Herein is discussed the synthesis of representative structures explored during the course of this work as detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Complete experimental details of all compounds described can additionally be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Reference quinoline <b>3</b> was synthesized from iodoquinoline starting material <b>27</b> via a sequence of Suzuki coupling to give phenylacetontrile <b>28</b>, followed by installation of the cyclobutyl moiety through double alkylation with dibromopropane (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The requisite amine was obtained following Curtius rearrangement of acid <b>30</b>, and hydrolysis of the relatively stable resulting isocyanate <b>31</b>, to give <b>3</b>. Starting with commercially available dichloropyridazine <b>32</b>, amination gave intermediate <b>33</b>, which was used in the synthesis of imidazopyridazine <b>5</b>. Reaction of <b>33</b> with chloroacetaldehyde gave bicycle <b>34</b>, which yielded target <b>5</b> following Suzuki coupling and deprotection to install the requisite cyclobutylamine side chain.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Reference Compound <b>3</b> and Imidazopyridazine Scaffold <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetonitrile, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 18 h; (ii) tetra-<i>n</i>-butylammonium bromide, 1,3-dibromopropane, toluene, water, 100 °C, 1 h; (iii) KOH, 2,2′-oxidiethanol, 245 °C, 75 min; (iv) DPPA, Et<sub>3</sub>N, dichloromethane, 25 °C, 4 h; (v) aq HCl, 60 °C, 5.5 h; (vi) NH<sub>3</sub>, ethanol, 150 °C, 24 h; (vii) 2-chloroacetaldehyde, H<sub>2</sub>O, 60 °C, 16 h; (viii) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, 1 h, then TFA, dichloromethane, rt, 1 h.</p></p></figure><div class="NLM_p">Pyrazolopyridine <b>39</b> was synthesized via a [3 + 2] cycloaddition between 1-aminopyridinium iodide and acetylenic ester <b>38</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), itself assembled in a short sequence from bromide <b>35</b> involving acetylenic coupling and double alkylation with ethyl chloroformate. Target scaffold <b>6</b> was subsequently obtained in a sequence involving ester hydrolysis, decarboxylative bromination to give <b>41</b>, followed by Suzuki coupling and deprotection. Its regioisomer <b>7</b> was obtained more simply from imidazopyridine <b>43</b> through a Suzuki–iodination–Suzuki coupling protocol to give <b>46</b> and then <b>7</b> via deprotection. 5-Bromo-6-chloropyrazin-2-amine served as starting material for synthesis of the imidazopyrazine core <b>11</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Judicious selection of boronic acid coupling partners allowed selective differentiation of first the bromo and then chloro functionalities to yield aminopyrazine <b>48</b>. Treatment with chloroacetaldehyde to form the imidazole ring and then deprotection afforded <b>11</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 6,5-Bridgehead-Based Scaffolds <b>6</b> and <b>7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) TMS–acetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, tetrahydrofuran, 70 °C, 12 h; (ii) K<sub>2</sub>CO<sub>3</sub>, methanol, rt, 1 h; (iii) LDA, tetrahydrofuran, ClCO<sub>2</sub>Et, −78 °C to rt, 1.5 h; (iv) 1-aminopyridinium iodide, DBU, CH<sub>3</sub>CN, 0 °C to rt, 18 h; (v) NaOH, ethanol, 100 °C, 2 h; (vi) NBS, Na<sub>2</sub>CO<sub>3</sub>, dimethylformamide, rt, 1 h; (vii) phenylboronic acid, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 15 min; (viii) TFA, dichloromethane, rt, 2 h; (ix) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 10 min; (x) NIS, CH<sub>3</sub>CN, rt, 1 h; (xi) phenylboronic acid, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 15 min; (xii) TFA, dichloromethane, rt, 2 h.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyrazine Scaffold <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, 100 °C, 2 h; (ii) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 1 h; (iii) 2-chloroacetaldehyde, H<sub>2</sub>O, dimethylformamide, 70 °C, 1.5 h then HCl, dioxane, dichloromethane, rt, 1 h.</p></p></figure><div class="NLM_p">Fused south naphthyridine analogue <b>15</b> was obtained using a procedure described by Wu.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Phenylacetylene <b>37</b> was coupled with an <i>o</i>-bromopyridine aldehyde to give <b>49</b>. The oxime product <b>50</b> formed by condensation with <i>O</i>-methylhydroxylamine was cyclized under copper catalysis conditions to give naphthyridine <b>51</b>. From here, Suzuki coupling to install the pendant phenyl ring and deprotection afforded the target <b>15</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Finally, pyridine scaffold <b>26</b> was synthesized by sequential selective Suzuki coupling on 5,6-dichloropyridine-3-carbonitrile (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Deprotection under acidic conditions resulted in concomitant hydrolysis of the nitrile group to primary amide <b>26</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Fused South Analogue <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) 4-bromopyridine-3-carbaldehyde, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 42 h; (ii) MeONH<sub>2</sub>.HCl, Et<sub>3</sub>N, dichloromethane, rt, 5.5 h; (iii) CuCl<sub>2</sub>, DMA, 100 °C, 3.5 h; (iv) phenylboronic acid, Pd(OAc)<sub>2</sub>, potassium orthophosphate, toluene, 80 °C, 2 h; (v) HCl, dioxane, dichloromethane, rt, 15 min.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Pyridine Scaffold <b>26</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, aq K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 18 h; (ii) phenylboronic acid, Pd(OAc)<sub>2</sub>, potassium orthophosphate, toluene, 80 °C, 2 h then HCl, dioxane, dichloromethane, methanol, rt, 3.5 h.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity and Structure–Property Relationships for Scaffolds with Bridgehead Nitrogen</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows enzyme and cell activity data together with measured log <i>D</i>, rat plasma protein binding, and aqueous solubility for the reference compound <b>3</b> together with a variety of alternative scaffolds that all feature a single bridgehead nitrogen atom. To incorporate this feature necessitates a switch to a 5,6-ring system (<b>4</b>, <b>5</b>), a 6,5-ring system (<b>6</b>–<b>8</b>), or, where the 6,6-ring is maintained as in <b>9</b>, incorporation of an exocyclic carbonyl group to maintain valence. All of these analogues maintain an sp<sup>2</sup> nitrogen at a position equivalent to that found in quinoline <b>3</b>. Compound <b>4</b> shows a drop in potency across all assays relative to the quinoline, and solubility is lower despite a similar log <i>D</i>. Interestingly, incorporation of an extra nitrogen in the five-membered ring, as in <b>5</b>, results in an increase in potency to give a profile close to that of the quinoline, albeit with much improved free drug (over 10-fold). Initially more speculative analogues such as <b>6</b> and <b>7</b>, in which the central six-membered-ring scaffold common to all existing disclosures is swapped for a five-membered ring, also show potent inhibition. Pyrazolopyridine <b>6</b> and imidazopyridine <b>7</b> show an activity similar to that of quinoline <b>3</b>, with the latter showing reduced lipophilicity and significantly improved free drug and solubility. An analogue of <b>7</b> with a primary carboxamide appended, <b>8</b> was synthesized since overlays with <b>1</b> indicated this vector overlays with the triazolone moiety. This modification resulted in improved potency with the IC<sub>50</sub> reaching sub-100 nM in cells, together with a significant drop in lipophilicity, although solubility remains modest. Pyridazinopyrimidinone <b>9</b> represents an interesting alternative core to quinoline <b>3</b>, showing a dramatically lowered log <i>D</i> and high solubility. In this case, however, potency in cells is substantially impacted; while it may be tempting to speculate a permeability issue due to low log <i>D</i>, the reduced activity in the enzyme assay suggests an inherent mismatch in binding at the target level.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Bicyclic Scaffolds with Bridgehead Nitrogen—Activity and Selected Physicochemical Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table 1</sup><p class="last">R1 = 4-phenylcyclobutyl-1-amine, R2 = Ph.</p></div><div class="footnote" id="t1fn2"><sup>Table 2</sup><p class="last">Inhibition of phosphorylation of Thr308 on AKT in BT474 cells.</p></div><div class="footnote" id="t1fn3"><sup>Table 3</sup><p class="last">Inhibition of phosphorylation of Ser473 on AKT in MDAMB468 cells.</p></div><div class="footnote" id="t1fn4"><sup>Table 4</sup><p class="last">Plasma protein binding in rat (Han Wistar).</p></div><div class="footnote" id="t1fn5"><sup>Table 5</sup><p class="last">Aqueous solubility measured at pH 7.4. All IC<sub>50</sub> data is reported as micromolar and is the mean of at least <i>n</i> = 2 data points, and each has a SEM ± 0.2 log units.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Activity and Structure–Property Relationships for Scaffolds with a Fused South Ring Structure</h3><div class="NLM_p">We next examined the effect of fusing a second ring to the lower part of the scaffold, a modification not reported in the literature. Initially, a series of 5,6-fused ring systems exemplified by <b>10</b>–<b>12</b> were synthesized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>10</b> and its aza-homologue <b>11</b> showed similar, if slightly reduced, activity to reference <b>3</b>, with a significant reduction in log <i>D</i> contributing to very high solubility and free drug levels in the case of <b>11</b>. Both of these analogues again exhibit a bridgehead nitrogen. Compound <b>12</b>, without this feature shows reduced activity, possibly due to the bulky nitrogen substituent causing unfavorable twists in the adjacent pendant aromatic groups. Moving on to examine 6,6-ring systems, compound <b>13</b> is the exact analogue of reference <b>3</b>, albeit now with an isoquinoline scaffold in place of quinoline. In this case, the potency and physicochemical property profile is indistinguishable from reference <b>3</b>. The effect of successive aza-substitution was examined in the four naphthyridine isomers <b>14</b>–<b>17</b>. Interestingly, each of these showed an improved potency over the corresponding isoquinoline/quinoline core. Aza substitution imparts over 1.5 log units lowered lipophilicity in each case, and this manifests in much improved solubility and good free drug levels. 1,7- And 2,7-napthyridines (<b>14</b> and <b>15</b>, respectively) appear preferred over 2,6- and 1,6-napthyridines (<b>16</b> and <b>17</b>, respectively).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Ring-Fused Scaffolds (South)—Activity and Selected Physicochemical Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table 1</sup><p class="last">R1 = 4-phenylcyclobutyl-1-amine, R2 = Ph.</p></div><div class="footnote" id="t2fn2"><sup>Table 2</sup><p class="last">Inhibition of phosphorylation of Thr308 on AKT in BT474 cells.</p></div><div class="footnote" id="t2fn3"><sup>Table 3</sup><p class="last">Inhibition of phosphorylation of Ser473 on AKT in MDAMB468 cells.</p></div><div class="footnote" id="t2fn4"><sup>Table 4</sup><p class="last">Plasma protein binding in rat (Han Wistar).</p></div><div class="footnote" id="t2fn5"><sup>Table 5</sup><p class="last">Aqueous solubility measured at pH 7.4. All IC<sub>50</sub> data is reported as micromolar and is the mean of at least <i>n</i> = 2 data points, and each has a SEM ± 0.2 log units.</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Structure–Activity and Structure–Property Relationships for Scaffolds with a Fused North Ring Structure</h3><div class="NLM_p">Literature exemplification of allosteric AKT inhibitors allude to the importance of the quinoline (or similar) ring nitrogen. Extending this work to look at ring fusion in the direction of this atom carried the risk then that activity may be significantly impacted. We speculated that incorporation of additional ring heteroatoms might be able to compensate for loss of the quinoline nitrogen. Gratifyingly, pyrazolopyridine <b>18</b> and imidazopyridine <b>19</b> both proved to be active, with the latter having a similar activity profile to quinoline <b>3</b>, with the additional benefit of a substantially lowered log <i>D</i>, albeit with similar solubility levels (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compound <b>20</b>, which does not contain a ring nitrogen atom in the vicinity of its position in quinoline <b>3</b>, shows reduced activity as anticipated. Triazolopyridine scaffold <b>21</b> represents a potent alternative to quinoline, again with a dramatically lowered log <i>D</i> and higher solubility. The alternative triazolopyridine isomer <b>22</b> shows slightly reduced potency. Whereas all of these scaffolds contain a bridgehead nitrogen, good potency is also achieved from a simple benzimidazole core <b>23</b>. Here, a reduced log <i>D</i> relative to quinoline is combined with a potentially useful additional vector for further optimization in the pendant <i>N</i>-methyl substituent. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> also contains additional scaffolds that were examined as part of this work. Quinazolone cores <b>24</b> and <b>25</b> are interesting, since they allow each of the pendant phenyl rings to be linked to the core via a nitrogen atom, as opposed to carbon in all previous examples. However, despite substantial log <i>D</i> and solubility improvements, both cores show severely compromised potency. As expected, the isomer <b>24</b> that retains a quinoline-like nitrogen demonstrates the most activity. The overall reduced potency, even in this case, may be due to unfavorable interaction between the lower carbonyl and pendant phenyl group, although QM calculations indicate minimal difference in the pendant phenyl torsion angle between <b>24</b> and quinoline <b>3</b>. Pyridine amide derivative <b>26</b> was also synthesized. Pyridine, specifically with a pendant nitrile group, has previously been validated as a scaffold for AKT inhibition,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> although only previously combined with extended lipophilic amine side chains; in this case, even with a much truncated basic side chain, good potency is maintained and is combined with exceptional free drug levels.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Ring-Fused Scaffolds (North), Quinazoline Scaffolds <b>24</b> and <b>25</b>, and Pyridine Scaffold <b>26</b>—Activity and Selected Physicochemical Data</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0010.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table 1</sup><p class="last">R1 = 4-phenylcyclobutyl-1-amine, R2 = Ph.</p></div><div class="footnote" id="t3fn2"><sup>Table 2</sup><p class="last">Inhibition of phosphorylation of Thr308 on AKT in BT474 cells.</p></div><div class="footnote" id="t3fn3"><sup>Table 3</sup><p class="last">Inhibition of phosphorylation of Ser473 on AKT in MDAMB468 cells.</p></div><div class="footnote" id="t3fn4"><sup>Table 4</sup><p class="last">Plasma protein binding in rat (Han Wistar).</p></div><div class="footnote" id="t3fn5"><sup>Table 5</sup><p class="last">Aqueous solubility measured at pH 7.4. All IC<sub>50</sub> data is reported as micromolar and is the mean of at least <i>n</i> = 2 data points, and each has a SEM ± 0.2 log units.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Docking Studies</h3><div class="NLM_p">The recently disclosed<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> crystal structure of an analogue of <b>1</b> was used as the basis for docking studies of the most potent inhibitor discovered here, compound <b>15</b> as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. A model of <b>15</b> was built<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and then docked<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> into the native crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O96">3O96</a>) using standard precision and no constraints. Satisfyingly, the docked molecule overlaid well with the literature compound (omitted for clarity), and we assume the same bridging water interaction between primary amine, Water 455, and Asn54. Trp80 appears to make a significant π–π stacking interaction with the aza isoquinoline scaffold of <b>15</b>, and may in part explain the high potency seen with a seemingly diverse set of heterocyclic scaffolds. The pendant naked phenyl substituent seen in all inhibitors sits in a relatively small lipophilic pocket bounded by Leu210, Leu264, Tyr272, Ile290, and Asp292, and the cyclobutyl ring sits in an adjacent pocket bounded by Tyr272, Asp274, and Gly294. No further optimization was performed.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>15</b> docked into AKT based on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O96">3O96</a>. Trp80 π–π stacks with the aza isoquinoline scaffold, and there is an assumed water-mediated hydrogen bond between the inhibitor primary amine and Asn54.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> DMPK and in Vivo Activity of Selected Examples</h3><div class="NLM_p">A selection of analogues that showed a good combination of potency and acceptable lipophilicity/solubility was examined in in vitro and in vivo DMPK assays, specifically rat and human in vitro hepatocyte clearance assays and rat iv and po studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Reference <b>3</b> was first benchmarked. This compound showed high rat in vitro clearance, but despite this, moderate in vivo clearance was observed, albeit with no oral exposure. Human in vitro clearance for this reference was significantly lower than in rat. Bridgehead analogues <b>5</b> and <b>6</b> both exhibited moderate to high clearance and consequently no oral exposure. Interestingly compound <b>7</b>, the positional isomer of <b>6</b>, shows a bioavailability of 36%, despite a moderately high in vivo clearance. Generally, the in vitro hepatocyte data predicted in vivo clearance within a reasonable spread in rat, where both data points existed. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> shows the predicted (from hepatocytes) versus measured in vivo clearance for the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, according to the well-stirred model.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In vivo clearance is predicted to within a 2-fold range, a reasonable approximation. Compound <b>11</b> shows a similar bioavailability, here combined with low in vitro clearance in both rat and human hepatocytes. Compound <b>15</b>, the most potent scaffold identified from this work, shows very high human in vitro clearance although modest rat in vivo clearance. Finally, pyridine analogue <b>26</b> shows the lowest clearance in both in vitro and in vivo assays and consequently good bioavailability of 48%. The combination of this compound’s good potency and very high free drug levels made it a candidate for further in vivo efficacy profiling.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> and Human in Vitro Metabolism and Rat in Vivo DMPK Properties</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Cl<sub>int</sub>(μL/min/10<sup>–6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char=".">rat hepatocytes </th><th class="colsep0 rowsep0" align="center" char=".">human hepatocytes </th><th class="colsep0 rowsep0" align="center" char=".">rat iv Cl<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">rat Vdss (l/kg)</th><th class="colsep0 rowsep0" align="center" char=".">rat po bioavailability %</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">148</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">274</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>6</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">171</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">291</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">10.3</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="char" char=".">48</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Han Wistar.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Blood clearance.</p></div></div></div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0012.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of predicted in vivo clearance values versus measured, based on in vitro scaling from rat hepatocyte data for selected compounds. The solid line is a 1:1 correlation and dotted lines represent ±2-fold spread.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Biological Activity</h3><div class="NLM_p">The biological activity and specific pharmacology of compound <b>26</b> was characterized by measuring the phosphorylation of its downstream substrate PRAS40 in the BT474c breast adenocarcinoma cell line. Compound <b>26</b> was shown to potently inhibit the phosphorylation of PRAS40 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Consistent with a prevention of activation mechanism of action, compound <b>26</b> also inhibited the phoshorylation of AKT on Ser473 and Thr308. Furthermore, compound <b>26</b> inhibited the phosphorylation of ribosomal protein S6, a downstream effector of the PI3K-AKT pathway. The effects of compound <b>26</b> in vivo were characterized by measuring the pharmacodynamic activity of this compound in a BT474c breast adenocarcinoma xenograft model. Following acute doses of 100  and 200 mg/kg, compound <b>26</b> potently inhibited the phosphorylation of its downstream substrate GSK3β as well as the phosphorylation of AKT (Ser473), with a potency consistent with its pharmacokinetic profile (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). The in vivo activity of compound <b>26</b> was further characterized by measuring the effects on the growth of tumor cell xenografts. Continuous (daily) oral dosing of compound <b>26</b> (100 and 200 mg/kg) to nude mice bearing BT474c breast adenocarcinoma xenografts resulted in inhibition of tumor growth in a dose-dependent manner. When dosed at 200 mg/kg daily, compound <b>26</b> caused significant tumor growth inhibition (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0013.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>26</b> on AKT pathway proteins in the BT474c breast adenocarcinoma cell line at 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0014.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic study of compound <b>26</b> in nude mice bearing a BT474c xenograft from a single oral dose of 100 and 200 mg/kg at 4 and 24 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0015.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Tumor growth inhibition study of compound <b>26</b> in BT474c xenografts growing in nude mice. Compound was dosed once a day orally for 21 days at 100 and 200 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Conclusions</h3><div class="NLM_p last">Inhibition of the AKT pathway represents a significant current focus for oncology drug discovery, and agents that target both active and inactive AKT are in clinical trials. Both profiles offer potential benefits and risks, and the true value of these individual strategies will emerge in due course. Known quinoline-based inhibitors of inactive AKT have demonstrated a unique cellular phenotype when compared with inhibitors of active kinase, and here we have demonstrated that a broad range of readily accessible alternative scaffold templates also have the potential to provide a platform for AKT inhibition, many with improved potency and physicochemical properties. Subsequent to this work, a range of other scaffolds has also been reported to effectively mimic quinolines in the context of AKT inhibition, such as imidazopyridines,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> furopyridines,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and chromenones,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> further broadening the pharmacophore for activity.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p last">All reactions were performed under inert conditions (nitrogen) unless otherwise stated. All solvents and reagents were purchased from commercial sources and used without further purification. For coupling reactions, all solvents were dried and degassed prior to reaction. Reactions performed under microwave irradiation utilized either a Biotage initiator or CEM Discover microwave. Upon workup, organic solvents were typically dried prior to concentration with anhydrous MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub>. Flash silica chromatography was typically performed on an Isco Companion, using Silicycle silica gel (230–400 mesh, 40–63 μm cartridges), Grace Resolv silica cartridges, or Isolute Flash Si or Si II cartridges. Reverse-phase chromatography was performed using a Waters XBridge Prep C18 OBD column (5 μm silica, 19 mm diameter, 100 mm length), using decreasingly polar mixtures of either water (containing 1% NH<sub>3</sub>) and MeCN, or water (containing 0.1% formic acid) and MeCN as eluents. Analytical LC–MS was performed on a Waters 2790 LC with a 996 PDA and 2000 amu ZQ single quadrupole mass spectrometer using a Phenomenex Gemini 50 × 2.1 mm, 5 μm, C18 column, or UPLC was performed on an Waters Acquity binary solvent manager with Acquity PDA and an SQD mass spectrometer using a 50 × 2.1 mm, 1.7 μm BEH column from Waters, and purities were measured by UV absorption at 254 nm or TIC and are ≥95% unless otherwise stated. NMR spectra were recorded on a Bruker Av400 or Bruker DRX400 spectrometer at 400 MHz in DMSO-<i>d</i><sub>6</sub> at 303 K unless otherwise indicated. <sup>1</sup>H NMR spectra are reported as chemical shifts in parts per million (ppm) relative to an internal solvent reference.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(4-(3-Phenylquinolin-2-yl)phenyl)acetonitrile (<b>28</b>)</h3><div class="NLM_p last">Pd(PPh<sub>3</sub>)<sub>4</sub> (0.21 g, 0.2 mmol) was added to 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile (0.94 g, 3.9 mmol), <b>27</b> (1.22 g, 3.7 mmol), and aq K<sub>2</sub>CO<sub>3</sub> (2 M, 5.53 mL, 11.1 mmol) in dioxane (31 mL) and the mixture stirred at 100 °C for 18 h. The reaction mixture was partitioned between ethyl acetate and water;  the organic layer was washed with water and then saturated brine, dried, and concentrated; and the crude product was purified by silica chromatography (5–30% ethyl acetate in isohexane) to afford <b>28</b> (1.1 g, 93%) as a yellow foam: <sup>1</sup>H NMR δ 4.05 (2H, s), 7.25–7.39 (7H, m), 7.39–7.47 (2H, m), 7.61–7.71 (1H, m), 7.82 (1H, ddd), 8.09 (2H, dd), 8.41 (1H, s); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 321.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-(4-(3-Phenylquinolin-2-yl)phenyl)cyclobutanecarbonitrile (<b>29</b>)</h3><div class="NLM_p last">Tetra-<i>n</i>-butylammonium bromide (0.025 g, 0.1 mmol), 1,3-dibromopropane (0.17 mL, 1.7 mmol), and <b>28</b> (0.5 g, 1.6 mmol) were added to KOH (0.44 g, 7.8 mmol) in toluene (3 mL) and water (0.23 mL) at 70 °C. The resulting mixture was heated at 100 °C for 70 min, cooled to room temperature, and diluted with toluene. The mixture was washed with water and concentrated and the crude product purified by silica chromatography (5–20% ethyl acetate in isohexane) to afford <b>29</b> (0.24 g, 42%) as a pale yellow solid: <sup>1</sup>H NMR δ 1.93–2.09 (1H, m), 2.19–2.37 (1H, m), 2.54–2.80 (4H, m), 7.25–7.45 (7H, m), 7.48 (2H, d), 7.67 (1H, t), 7.77–7.88 (1H, m), 8.09 (2H, d), 8.42 (1H, s); <i>m</i>/<i>z</i> (ES+), (M + H)<sup>+</sup> = 361.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-(4-(3-Phenylquinolin-2-yl)phenyl)cyclobutanecarboxylic Acid (<b>30</b>)</h3><div class="NLM_p last">KOH (111 mg, 2 mmol) was added to <b>29</b> (238 mg, 0.7 mmol) in 2,2′-oxidiethanol (1.9 mL) and the resulting mixture stirred at 245 °C for 75 min in a microwave reactor. The reaction mixture was allowed to cool to room temperature, diluted with water, and adjusted to pH 4.6 with aq HCl (2 M). The precipitate was collected by filtration, washed with water, and dried and the crude product purified by silica chromatography (0–100% ethyl acetate in dichloromethane) to afford <b>30</b> (135 mg, 54%) as a beige solid: <sup>1</sup>H NMR δ 1.80 (1H, dq), 1.86–2.02 (1H, m), 2.37 (2H, ddd), 2.63–2.76 (2H, m), 7.21 (2H, d), 7.26–7.43 (7H, m), 7.65 (1H, dd), 7.76–7.86 (1H, m), 8.07 (2H, d), 8.39 (1H, s), 12.32 (1H, s); <i>m</i>/<i>z</i> (ES+), (M + H)<sup>+</sup> = 380.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(4-(1-Isocyanatocyclobutyl)phenyl)-3-phenylquinoline (<b>31</b>)</h3><div class="NLM_p last">DPPA (92 μL, 0.4 mmol) was added to <b>30</b> (108 mg, 0.3 mmol) and Et<sub>3</sub>N (59 μL, 0.4 mmol) in dichloromethane (1 mL) and the mixture stirred at 25 °C for 4 h. The reaction mixture was diluted with dichloromethane and water, and the organic layer was washed with brine, dried, and concentrated to afford <b>31</b> (107 mg) which was used without further purification: <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 377.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-(4-(3-Phenylquinolin-2-yl)phenyl)cyclobutanamine (<b>3</b>)</h3><div class="NLM_p last">Compound <b>31</b> (107 mg, 0.3 mmol) in aq HCl (2 M, 2.5 mL, 5 mmol) was stirred at 60 °C for 5.5 h. The reaction mixture was cooled to room temperature, diluted with methanol, and purified by ion exchange chromatography, using a 5 g SCX-3 column (7 M NH<sub>3</sub>/methanol) to afford crude product which was further purified by silica chromatography (50–100% ethyl acetate in isohexane) to afford <b>3</b> (59 mg, 60%) as a white foamy solid: <sup>1</sup>H NMR δ 1.57–1.71 (1H, m), 1.93–2.12 (5H, m), 2.30–2.42 (2H, m), 7.27–7.41 (9H, m), 7.60–7.68 (1H, m), 7.80 (1H, ddd), 8.07 (2H, dd), 8.38 (1H, s); HRMS <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 351.185 36 (theoretical 351.185 58).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 6-Chloro-5-phenylpyridazin-3-amine (<b>33</b>)</h3><div class="NLM_p last">NH<sub>3</sub> in methanol (7 M, 2.29 mL, 16 mmol) and <b>32</b> (1 g, 4.4 mmol) were dissolved in ethanol (14.1 mL) and heated at 150 °C for 24 h in a microwave reactor and then cooled to room temperature. The reaction mixture was evaporated, dissolved in dichloromethane (100 mL), and washed sequentially with saturated aq NaHCO<sub>3</sub> (50 mL) and brine (50 mL). The organic layer was dried and evaporated to afford crude product which was purified by silica chromatography (0–5% methanol in dichloromethane) to afford <b>33</b> (0.45 g, 49%) as a white solid: <sup>1</sup>H NMR δ 6.66 (2H, s), 6.80 (1H, s), 7.45–7.56 (5H, m); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 206.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 6-Chloro-7-phenylimidazo[1,2-<i>b</i>]pyridazine (<b>34</b>)</h3><div class="NLM_p last">Compound <b>33</b> (360 mg, 1.8 mmol) in ethanol (4 mL) was stirred at 60 °C. Aqueous 2-chloroacetaldehyde (55%, 2.0 mL, 7 mmol) was added dropwise, and the reaction mixture was stirred at 60 °C for 16 h, cooled to room temperature,  diluted with ethyl acetate (30 mL), washed with saturated aq NaHCO<sub>3</sub> (2 × 20 mL), dried, and evaporated to give a solid. The solid was triturated with isohexane and collected by filtration to afford <b>34</b> (325 mg, 81%) as a pale yellow solid: <sup>1</sup>H NMR δ 7.45–7.59 (5H, m), 7.89 (1H, d), 8.21 (1H, d), 8.37–8.40 (1H, m); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 230.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-(7-Phenylimidazo[1,2-<i>b</i>]pyridazin-6-yl)phenyl)cyclobutanamine (<b>5</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutylcarbamate (163 mg, 0.4 mmol), <b>34</b> (100 mg, 0.4 mmol), diacetoxyzinc (88 mg, 0.5 mmol), aq Na<sub>2</sub>CO<sub>3</sub> (2 M, 653 μL, 1.3 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (25 mg, 0.02 mmol) were suspended in dioxane and heated at 100 °C for 2 h in a microwave reactor and then cooled to room temperature, and the organic phase was decanted from the solidified Na<sub>2</sub>CO<sub>3</sub> layer. The reaction mixture was evaporated to dryness to afford crude product which was purified by silica chromatography (0–5% methanol in dichloromethane) to afford a yellow oil. TFA (454 μL) was added to a solution of this in dichloromethane (454 μL) and the solution was stirred at room temperature for 1 h. The reaction mixture was evaporated and dissolved in methanol. The crude product was purified by ion exchange chromatography, using an SCX column (7 M NH<sub>3</sub>/methanol) to afford crude product. The product was further purified by silica chromatography (0–10% methanol in dichloromethane) to afford <b>5</b> (37 mg, 48%) as a white crystalline solid: <sup>1</sup>H NMR (MeOD) δ 1.69–1.84 (1H, m), 2.02–2.15 (1H, m), 2.21–2.33 (2H, m), 2.50–2.60 (2H, m), 7.20–7.33 (5H, m), 7.33–7.43 (4H, m), 7.80 (1H, d), 7.95 (1H, d), 8.15–8.19 (1H, m), 1 × NH<sub>2</sub> not observed; <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 341.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl <i>N</i>-[1-[4-(2-Trimethylsilylethynyl)phenyl]cyclobutyl]carbamate (<b>36</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 1-(4-bromophenyl)cyclobutylcarbamate <b>35</b> (4 g, 12.3 mmol) and ethynyltrimethylsilane (4.25 mL, 30.7 mmol) were stirred in tetrahydrofuran (150 mL). Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.43 g, 0.6 mmol), CuI (47 mg, 0.25 mmol), and triphenylphosphine (0.32 g, 1.2 mmol) were added, followed by triethylamine (5.13 mL, 36.8 mmol). The solution was heated at 70 °C for 18 h. Further portions of Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.22 g, 0.3 mmol) and CuI (23 mg, 0.12 mmol) were added followed by ethynyltrimethylsilane (2.12 mL, 15.3 mmol), and stirring was continued under nitrogen at 70 °C for 5 h, and then the mixture was allowed to cool to room temperature. The reaction mixture was filtered, concentrated, and then purified by silica chromatography (0–6% ethyl acetate in isohexane) to afford <b>36</b> (930 mg, 22%) as a yellow solid: <sup>1</sup>H NMR δ 0.00 (9H, s), 0.95 and 1.09 (9H, 2 × bs), 1.45–1.61 (1H, m), 1.67–1.82 (1H, m), 2.06–2.20 (4H, m), 7.15 (4H, dd), 7.38 (1H, s); <i>m</i>/<i>z</i> (ES−) (M – H)<sup>−</sup> = 342.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>tert</i>-Butyl 1-(4-Ethynylphenyl)cyclobutylcarbamate (<b>37</b>)</h3><div class="NLM_p last">Compound <b>36</b> (930 mg, 2.7 mmol) was dissolved in methanol (45 mL) and K<sub>2</sub>CO<sub>3</sub> (4.62 g, 33.4 mmol) was added. The slurry was stirred at room temperature for 2.5 h and then concentrated. Water (40 mL) was added and the mixture was extracted with ethyl acetate (3 × 25 mL). The combined extracts were washed with brine, dried, and evaporated to afford <b>37</b> (0.73 g, 22%) as a brown gum which was used without further purification: <sup>1</sup>H NMR δ 0.90 and 1.10 (9H, 2 × bs), 1.47–1.63 (1H, m), 1.68–1.84 (1H, m), 2.06–2.23 (4H, m), 3.87 (1H, s), 7.08–7.31 (4H, m), 7.39 (1H, bs); <i>m</i>/<i>z</i> (ES−) (M–H)<sup>−</sup> = 270.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Ethyl 3-(4-(1-(<i>tert</i>-Butoxycarbonyl(ethoxycarbonyl)amino)cyclobutyl)phenyl)propiolate (<b>38</b>)</h3><div class="NLM_p last">LDA in tetrahydrofuran (1.8 M, 0.74 mL, 1.3 mmol) was added to <b>37</b> (100 mg, 0.4 mmol) in tetrahydrofuran (5 mL) at −78 °C. The resulting solution was stirred at −78 °C for 20 min, ethyl chloroformate (0.12 mL, 1.3 mmol) was added, and the mixture was allowed to warm to room temperature and stirred for 1 h. The reaction was diluted with ethyl acetate (10 mL) and washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried and evaporated to afford crude product which was purified by silica chromatography (0–20% ethyl acetate in isohexane) to afford <b>38</b> (99 mg, 65%) as a colorless oil: <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.25 (3H, t), 1.36 (3H, t), 1.41 (9H, s), 1.72–1.90 (2H, m), 2.52–2.71 (4H, m), 4.18 (2H, q), 4.25–4.33 (2H, m), 7.53–7.59 (2H, m), 7.64–7.68 (2H, m). No molecular ion was observable.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl 2-(4-(1-(<i>tert</i>-Butoxycarbonyl(ethoxycarbonyl)amino)cyclobutyl)phenyl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxylate (<b>39</b>)</h3><div class="NLM_p last">A solution of DBU (286 mg, 1.9 mmol) in acetonitrile (5 mL) was added dropwise to <b>38</b> (390 mg, 0.9 mmol) and 1-aminopyridinium iodide (208 mg, 0.9 mmol) in acetonitrile (20 mL) at 0 °C. The resulting mixture was stirred at 0 °C for 30 min and then at room temperature for 18 h. The reaction mixture was diluted with ethyl acetate (10 mL) and washed with water (2 × 10 mL) and brine (10 mL). The organic layer was dried and evaporated to afford crude product which was purified by silica chromatography (0–20% ethyl acetate in isohexane) to afford <b>39</b> (407 mg, 85%) as a colorless oil: <sup>1</sup>H NMR δ 1.16 (6H, dt), 1.33 (9H, s), 1.64–1.73 (1H, m), 1.73–1.83 (1H, m), 2.46–2.63 (4H, m), 4.06 (2H, q), 4.18 (2H, q), 7.12 (1H, td), 7.52–7.59 (1H, m), 7.62 (2H, d), 7.70 (2H, d), 8.09 (1H, d), 8.81 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 508.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(4-(1-(<i>tert</i>-Butoxycarbonylamino)cyclobutyl)phenyl)pyrazolo[1,5-<i>a</i>]pyridine-3-carboxylic Acid (<b>40</b>)</h3><div class="NLM_p last">Aqueous NaOH (2 M, 3.8 mL, 1 mmol) was added to <b>39</b> (45 mg, 0.1 mmol) in ethanol (2 mL). The resulting solution was stirred at 100 °C for 2 h and then cooled to room temperature. The reaction was concentrated and acidified with aq HCl (2 M) and then filtered to afford <b>40</b> (310 mg, 97%) as a white solid: <sup>1</sup>H NMR δ 1.36 (9H, s), 1.84 (1H, s), 1.95–2.10 (1H, m), 2.43 (4H, t), 7.15 (1H, t), 7.45 (2H, d), 7.52–7.63 (2H, m), 7.75 (2H, d), 8.16 (1H, d), 8.83 (1H, d), 12.26 (1H, s); <i>m</i>/<i>z</i> (ES−) (M – H)<sup>−</sup> = 406.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 1-(4-(3-Bromopyrazolo[1,5-<i>a</i>]pyridin-2-yl)phenyl)cyclobutylcarbamate (<b>41</b>)</h3><div class="NLM_p last">Compound <b>40</b> (290 mg, 0.7 mmol), Na<sub>2</sub>CO<sub>3</sub> (179 mg, 2.1 mmol), and NBS (127 mg, 0.7 mmol) in dimethylformamide (2 mL) were stirred at room temperature for 1 h. The mixture was poured into water (150 mL) and the resulting solid collected by filtration and washed with water to afford <b>41</b> (288 mg, 91%) as a white solid: <sup>1</sup>H NMR δ 1.35 (9H, s), 1.78–1.88 (1H, m), 1.98–2.08 (1H, m), 2.44 (4H, t), 7.03 (1H, t), 7.37–7.44 (1H, m), 7.54 (2H, d), 7.62 (2H, d), 7.95 (2H, d), 8.77 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 444.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>tert</i>-Butyl 1-(4-(3-Phenylpyrazolo[1,5-<i>a</i>]pyridin-2-yl)phenyl)cyclobutylcarbamate (<b>42</b>)</h3><div class="NLM_p last">Phenylboronic acid (127 mg, 1 mmol), aq Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.52 mL, 1 mmol), <b>41</b> (230 mg, 0.5 mmol) and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (37 mg, 0.05 mmol) were suspended in 18% dimethylformamide in 1,2-dimethoxyethane/water/ethanol (7:3:2) (2 mL), heated at 150 °C for 15 min in a microwave reactor, and then cooled to room temperature. The reaction mixture was diluted with ethyl acetate (20 mL) and washed with water (2 × 20 mL) and brine (20 mL). The organic layer was dried and concentrated and the residue purified by flash silica chromatography (55–80% acetonitrile in water +1% NH<sub>4</sub>OH) to afford <b>42</b> (138 mg, 60%) as a white solid: <sup>1</sup>H NMR δ 1.06–1.41 (9H, m), 1.79 (1H, s), 1.99 (1H, s), 2.31–2.44 (4H, m), 6.97 (1H, td), 7.23–7.32 (1H, m), 7.35 (5H, d), 7.42 (2H, d), 7.47 (2H, d), 7.53–7.64 (2H, m), 8.76 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 440.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(4-(3-Phenylpyrazolo[1,5-<i>a</i>]pyridin-2-yl)phenyl)cyclobutanamine (<b>6</b>)</h3><div class="NLM_p last">A solution of TFA in dichloromethane (10%, 10 mL) was added to <b>42</b> (134 mg, 0.3 mmol), and the mixture was stirred at room temperature for 2 h and then concentrated. The crude product was purified by ion exchange chromatography, using an SCX column (7 M NH<sub>3</sub>/methanol) to afford <b>6</b> (103 mg, 100%) as a white solid: <sup>1</sup>H NMR δ 1.60–1.72 (1H, m), 1.97–2.05 (1H, m), 2.06–2.15 (2H, m), 2.39 (2H, ddd), 2.72 (2H, bs), 6.97 (1H, td), 7.27 (1H, ddd), 7.36 (3H, dt), 7.41–7.48 (4H, m), 7.53 (3H, dd), 8.76 (1H, d); HRMS <i>m</i>/<i>z</i> (ES+) M<sup>+</sup> = 340.180 57 (theoretical 340.180 82).</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl 1-(4-(Imidazo[1,2-<i>a</i>]pyridin-2-yl)phenyl)cyclobutylcarbamate (<b>44</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutylcarbamate (284 mg, 0.8 mmol), aq Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.31 mL, 0.6 mmol), <b>43</b> (100 mg, 0.5 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (36 mg, 0.05 mmol) were suspended in 18% dimethylformamide in 1,2-dimethoxyethane/water/ethanol (7:3:2) (2.0 mL), and the mixture was heated at 150 °C for 10 min in a microwave reactor and then cooled to room temperature. The reaction mixture was diluted with ethyl acetate (20 mL) and washed with water (2 × 20 mL) and brine (20 mL). The organic layer was dried and evaporated to afford crude product which was purified by flash silica chromatography, with an elution gradient from 0 to 50% ethyl acetate in isohexane, to afford <b>44</b> (140 mg, 76%) as a white solid: <sup>1</sup>H NMR δ 1.32 (9H, d), 1.82 (1H, s), 1.97–2.07 (1H, m), 2.42 (4H, t), 6.89 (1H, td), 7.18–7.29 (1H, m), 7.44 (2H, d), 7.57 (2H, d), 7.91 (2H, d), 8.36 (1H, s), 8.52 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 364.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl 1-(4-(3-Iodoimidazo[1,2-<i>a</i>]pyridin-2-yl)phenyl)cyclobutylcarbamate (<b>45</b>)</h3><div class="NLM_p last">NIS (222 mg, 1 mmol) was added to <b>44</b> (342 mg, 0.9 mmol) in acetonitrile (10 mL). The resulting solution was stirred at room temperature for 1 h and then evaporated, and the residue was dissolved in ethyl acetate (25 mL) and washed with aq NaOH (10% w/v, 25 mL), water (25 mL), and brine (25 mL). The organic layer was dried and evaporated to afford <b>45</b> (460 mg, 100%) as a yellow oil: <sup>1</sup>H NMR δ 1.29 (9H, d), 1.82 (1H, s), 1.95–2.06 (1H, m), 2.43 (4H, t), 7.08 (1H, td), 7.31–7.41 (1H, m), 7.50 (2H, d), 7.58–7.66 (2H, m), 8.02 (2H, d), 8.42 (1H, d); <i>m</i>/<i>z</i> (ES+) M+ = 490.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>tert</i>-Butyl 1-(4-(3-Phenylimidazo[1,2-<i>a</i>]pyridin-2-yl)phenyl)cyclobutylcarbamate (<b>46</b>)</h3><div class="NLM_p last">Phenylboronic acid (168 mg, 1.4 mmol), aq Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.7 mL, 1.4 mmol), <b>45</b> (450 mg, 0.9 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (65 mg, 0.1 mmol) were suspended in 18% dimethylformamide in 1,2-dimethoxyethane/water/ethanol (7:3:2) (6 mL), heated at 150 °C for 15 min in a microwave reactor, and then cooled to room temperature. The reaction mixture was diluted with ethyl acetate (20 mL) and washed with water (2 × 20 mL) and brine (20 mL). The organic layer was dried and concentrated and the crude product purified by silica chromatography (0–70% ethyl acetate in isohexane) to afford <b>46</b> (259 mg, 64%) as a white solid: <sup>1</sup>H NMR δ 1.31 (9H, s), 1.66–1.84 (1H, m), 1.90–2.03 (1H, m), 2.25–2.45 (4H, m), 6.88 (1H, t), 7.23–7.37 (3H, m), 7.42–7.70 (9H, m), 7.99 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 440.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(4-(3-Phenylimidazo[1,2-<i>a</i>]pyridin-2-yl)phenyl)cyclobutanamine (<b>7</b>)</h3><div class="NLM_p last">TFA in dichloromethane (10%, 5 mL) was added to <b>46</b> (85 mg, 0.2 mmol) and the solution was stirred at room temperature for 2 h and then concentrated. The crude product was purified by ion exchange chromatography, using an SCX column (7 M NH<sub>3</sub>/methanol) to afford <b>7</b> (64 mg, 98%) as a white solid: <sup>1</sup>H NMR δ 1.58–1.72 (1H, m), 1.93–2.05 (1H, m), 2.06–2.19 (2H, m), 2.34–2.45 (2H, m), 3.6 (2H,s), 6.89 (1H, td), 7.26–7.35 (1H, m), 7.38 (2H, d), 7.47–7.70 (8H, m), 7.99 (1H, d); HRMS <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 340.180 69 (theoretical 340.180 82).</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(4-(5-Amino-3-chloropyrazin-2-yl)phenyl)cyclobutylcarbamate (<b>47</b>)</h3><div class="NLM_p last">A tube was charged with 5-bromo-6-chloropyrazin-2-amine (100 mg, 0.5 mmol), <i>tert</i>-butyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutylcarbamate (179 mg, 0.5 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (42 mg, 0.04 mmol) in dioxane (2 mL) and aq Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.48 mL, 1 mmol) and the reaction heated at 100 °C under microwave irradiation for 2 h. The reaction was filtered and evaporated and the crude product purified by silica chromatography (0–6% methanol in dichloromethane) to afford <b>47</b> (162 mg, 90%) as a yellow solid: <sup>1</sup>H NMR δ 1.17 and 1.35 (9H, 2 × bs), 1.82 (1H, s), 2.00 (1H, s), 2.41 (4H, s), 6.94 (2H, s), 7.43 (2H, d), 7.59 (2H, d), 7.93 (1H, s); <i>m</i>/<i>z</i> (ES−) (M – H)<sup>−</sup> = 373.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>tert</i>-Butyl 1-(4-(5-Amino-3-phenylpyrazin-2-yl)phenyl)cyclobutylcarbamate (<b>48</b>)</h3><div class="NLM_p last">A tube was charged with <b>47</b> (160 mg, 0.4 mmol), phenylboronic acid (57 mg, 0.5 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (49 mg, 0.04 mmol) in dioxane (2 mL) and aq Na<sub>2</sub>CO<sub>3</sub>, (2 M, 0.43 mL, 0.9 mmol) and then heated at 110 °C under microwave irradiation for 50 min. The reaction mixture was allowed to cool to room temperature, filtered, and evaporated. The crude product was purified by silica chromatography (20–60% ethyl acetate in isohexane) to afford <b>48</b> (70 mg, 39%) as a white solid: <sup>1</sup>H NMR δ 1.16 and 1.32 (9H, 2 × bs), 1.76 (1H, bm), 1.99 (1H, bm), 2.26–2.42 (4H, m), 6.52 (2H, s), 7.16–7.35 (9H, m), 7.46 (1H, bs), 7.95 (1H, s); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 417.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(4-(5-Phenylimidazo[1,2-<i>a</i>]pyrazin-6-yl)phenyl)cyclobutanamine Hydrochloride (<b>11</b>)</h3><div class="NLM_p last">A mixture of <b>48</b> (75 mg, 0.2 mmol) and aq 2-chloroacetaldehyde (55%, 0.21 mL, 1.8 mmol) in dimethylformamide (2.5 mL) was heated at 70 °C for 1.5 h. The solution was allowed to cool to room temperature,  diluted with ethyl acetate (25 mL), and washed with saturated aq NaHCO<sub>3</sub> (2 × 15 mL). The organic layer was dried, filtered, and evaporated and crude product purified by silica chromatography (0–3% methanol in dichloromethane) to afford a pale yellow glassy solid. The solid was dissolved in dichloromethane (2.5 mL), and HCl in dioxane (4M, 2 mL) was added dropwise. The solution was stirred at room temperature for 1 h and then evaporated to dryness to afford <b>11</b> (42 mg, 56%) as a pale orange solid: <sup>1</sup>H NMR δ 1.77–1.89 (1H, m), 2.16–2.28 (1H, m), 2.54–2.63 (4H, m, partially obscured by DMSO peak), 7.46–7.53 (4H, m), 7.58–7.66 (6H, m), 7.99 (1H, s), 8.72 (3H, bs), 9.36 (1H, s); HRMS <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 341.176 12 (theoretical 341.176 07).</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 1-(4-((3-Formylpyridin-4-yl)ethynyl)phenyl)cyclobutylcarbamate (<b>49</b>)</h3><div class="NLM_p last">A solution of 4-bromoisonicotinaldehyde hydrobromide (157 mg, 0.6 mmol) and <b>37</b> (160 mg, 0.6 mmol) in acetonitrile (6 mL) was degassed with a stream of nitrogen. Pd(PPh<sub>3</sub>)<sub>4</sub> (34 mg, 0.03 mmol), CuI (2.2 mg, 0.01 mmol), and Et<sub>3</sub>N (0.25 mL, 1.8 mmol) were added and the mixture was stirred under nitrogen at room temperature for 4 days. The reaction mixture was filtered and evaporated to dryness. The residue was purified by silica chromatography (10–35% ethyl acetate in isohexane) to afford <b>49</b> (106 mg, 48%) as an orange solid: <sup>1</sup>H NMR δ 1.18 and 1.29 (9H, 2 × bs), 1.73–1.88 (1H, m), 1.94–2.09 (1H, m), 2.35–2.46 (4H, m), 7.49 (2H, d), 7.63–7.76 (4H, m), 8.84 (1H, d), 9.03 (1H, s), 10.48 (1H, s); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 377.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl <i>N</i>-[1-[4-[2-[3-[(<i>E</i>)-Methoxyiminomethyl]pyridin-4-yl]ethynyl]phenyl]cyclobutyl]carbamate (<b>50</b>)</h3><div class="NLM_p last">To a solution of <b>49</b> (105 mg, 0.3 mmol) in dichloromethane (4 mL) was added Et<sub>3</sub>N (0.04 mL, 0.3 mmol) followed by <i>O</i>-methylhydroxylamine hydrochloride (26 mg, 0.3 mmol). The solution was stirred overnight,  diluted with dichloromethane (15 mL), and washed with water (15 mL). The aqueous phase was extracted with dichloromethane (2 × 15 mL). The combined extracts were washed with brine, dried, and evaporated to afford <b>50</b> (109 mg, 96%) as a brown gum. UPLC shows a mixture of cis and trans oxime isomers: <sup>1</sup>H NMR δ 1.18 and 1.29 (9H, 2 × bs), 1.72–1.86 (1H, m), 1.93–2.08 (1H, m), 2.34–2.46 (4H, m), 3.99 (3H, d), 7.44–7.51 (2H, m), 7.56–7.73 (4H, m), 8.54 (1H, s), 8.58–8.67 (1H, m), 8.95 (1H, s); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 406.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>tert</i>-Butyl <i>N</i>-[1-[4-(4-Chloro-2,7-naphthyridin-3-yl)phenyl]cyclobutyl]carbamate (<b>51</b>)</h3><div class="NLM_p last">A solution of <b>50</b> (107 mg, 0.3 mmol) in DMA (1.5 mL) and CuCl<sub>2</sub> (71 mg, 0.5 mmol) was heated at 100 °C for 2 h. The solution was cooled to room temperature, diluted with ethyl acetate (5 mL), and quenched with water (5 mL). The mixture was filtered and extracted with ethyl acetate (2 × 5 mL), washed with brine, dried, and evaporated. The crude product was purified by silica chromatography (20–65% ethyl acetate in isohexane) to afford <b>51</b> (27 mg, 25%) as a colorless crystalline solid: <sup>1</sup>H NMR δ 1.20 and 1.36 (9H, 2 × bs), 1.78–1.92 (1H, m), 1.97–2.10 (1H, m), 2.40–2.51 (4H, m) partially obscured by DMSO peak, 7.53–7.58 (2H, m), 7.67 (1H, bs), 7.76–7.82 (2H, m), 8.12 (1H, d), 8.94 (1H, d), 9.61 (1H, d), 9.65 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 410.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>tert</i>-Butyl <i>N</i>-[1-[4-(4-Phenyl-2,7-naphthyridin-3-yl)phenyl]cyclobutyl]carbamate (<b>52</b>)</h3><div class="NLM_p last">Toluene (1.5 mL) was added to a mixture of <b>51</b> (25 mg, 0.06 mmol), phenylboronic acid (11.2 mg, 0.1 mmol), S-Phos (2.5 mg, 0.01 mmol), Pd(OAc)<sub>2</sub> (0.7 mg, 3.1 μmol), and powdered anhydrous potassium orthophosphate (26 mg, 0.1 mmol). The mixture was heated at 80 °C for 2 h. The reaction mixture was cooled to room temperature, diluted with ethyl acetate (6 mL), filtered, and concentrated. The crude product was purified by silica chromatography (0–3.5% methanol in dichloromethane) to afford <b>52</b> (26 mg, 94%) as a colorless gum: <sup>1</sup>H NMR δ 1.13 and 1.29 (9H, 2 × bs), 1.68–1.83 (1H, m), 1.90–2.03 (2H, m), 2.27–2.40 (4H, m), 7.24 (2H, d), 7.27–7.32 (2H, m), 7.32–7.37 (3H, m), 7.39–7.47 (3H, m), 7.46 (1H, s), 8.70 (1H, d), 9.62 (1H, d), 9.66 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 452.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(4-(4-Phenyl-2,7-naphthyridin-3-yl)phenyl)cyclobutanamine (<b>15</b>)</h3><div class="NLM_p last">HCl in dioxane (4 M, 1 mL, 4 mmol) was added dropwise to a solution of <b>52</b> (25 mg, 0.06 mmol) in dichloromethane (1 mL), and the resulting yellow suspension was stirred at room temperature for 30 min. The mixture was evaporated to dryness to afford <b>15</b> (20 mg, 92%) as a yellow solid (hydrochloride): <sup>1</sup>H NMR δ 1.71–1.85 (1H, m), 2.11–2.24 (1H, m), 2.49–2.59 (4H, m), 7.32–7.38 (2H, m), 7.43–7.55 (8H, m), 8.74 (3H, bs), 8.75 (1H, d), 9.81 (1H, d), 9.82 (1H, d); <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 352.</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>tert</i>-Butyl 1-(4-(3-Chloro-5-cyanopyridin-2-yl)phenyl)cyclobutylcarbamate (<b>53</b>)</h3><div class="NLM_p last">A solution of 5,6-dichloropyridine-3-carbonitrile (80 mg, 0.5 mmol), <i>tert</i>-butyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutylcarbamate (173 mg, 0.5 mmol), and 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride (30 mg, 0.05 mmol) in acetonitrile (1.5 mL) and aq K<sub>2</sub>CO<sub>3</sub> (2 M, 0.46 mL, 0.9 mmol) was heated at reflux for 18 h and then allowed to cool to room temperature and filtered. The filtrate was evaporated to dryness and crude product purified by silica chromatography (0–1% methanol in dichloromethane) to afford <b>53</b> (124 mg, 70%) as a pale yellow gum; <i>m</i>/<i>z</i> (ES−) (M – tBuOH)<sup>−</sup> = 308.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 6-(4-(1-Aminocyclobutyl)phenyl)-5-phenylnicotinamide (<b>26</b>)</h3><div class="NLM_p last">Toluene (1 mL) was added to a mixture of <b>53</b> (60 mg, 0.2 mmol), phenylboronic acid (29 mg, 0.2 mmol), S-Phos (3.85 mg, 9.38 μmol), Pd(OAc)<sub>2</sub> (1 mg, 4.7 μmol), and powdered anhydrous potassium orthophosphate (66 mg, 0.3 mmol). The mixture was heated at 80 °C for 2 h. The reaction mixture was allowed to cool to room temperature, diluted with ethyl acetate (4 mL), and filtered. The filtrate was evaporated and the crude product purified by silica chromatography (0–15% ethyl acetate in isohexane) to afford a white solid. The solid was dissolved in dichloromethane (1.5 mL) and methanol (1.5 mL),  then HCl in dioxane (4 M, 6 mL, 24 mmol) was added, and the yellow solution was stirred for 3.5 h. The solution was evaporated to dryness, and the residue was triturated with a mixture of aq K<sub>2</sub>CO<sub>3</sub> (2 M, 5 mL) and ethyl acetate (5 mL), filtered, and washed with water and ethyl acetate to afford <b>26</b> (34 mg, 63%) as a white solid: <sup>1</sup>H NMR δ 1.59–1.71 (1H, m), 1.94–2.15 (3H, m), 2.31–2.42 (2H, m), 3.09 (2H, bs), 7.24–7.40 (9H, m), 7.60 (1H, s), 8.22 (2H, d), 9.09 (1H, d); HRMS <i>m</i>/<i>z</i> (ES+) (M + H)<sup>+</sup> = 344.175 66 (theoretical 344.175 74).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/jm201394e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Details of the full synthesis and spectroscopic characterization of all additional compounds and intermediates, in addition to all protocols for in vitro and in vivo experiments. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201394e/suppl_file/jm201394e_si_001.pdf">jm201394e_si_001.pdf (267.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201394e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason G. Kettle</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1d777c6e7273337678696971785d7c6e696f7c677873787e7c337e7270"><span class="__cf_email__" data-cfemail="0f656e7c606121646a7b7b636a4f6e7c7b7d6e756a616a6c6e216c6062">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Brown</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Crafter</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry R. Davies</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phillippa Dudley</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Fairley</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Faulder</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shaun Fillery</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah Greenwood</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janet Hawkins</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael James</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Johnson</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clare D. Lane</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Pass</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer H. Pink</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helen Plant</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabina C. Cosulich</span> - <span class="hlFld-Affiliation affiliation">Oncology iMED, AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, United Kingdom</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i54" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i54"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> Abbreviations Used</h2><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">PDK1</td><td class="NLM_def"><p class="first last">3-phosphoinositide dependent protein kinase-1</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">PH</td><td class="NLM_def"><p class="first last">pleckstrin homology</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0ljc8RzwQOgrKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">The PI3K pathway as a drug target in human cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1200%2FJCO.2009.25.3641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20085938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1075-1083&author=K.+D.+Courtneyauthor=B.+Ryanauthor=J.+A.+Engelman&title=The+PI3K+pathway+as+a+drug+target+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The PI3K pathway as drug target in human cancer</span></div><div class="casAuthors">Courtney, Kevin D.; Corcoran, Ryan B.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth, survival, motility, and metab.  This pathway is activated by several different mechanisms in cancers, including somatic mutation and amplification of genes encoding key components.  In addn., PI3K signaling may serve integral functions for noncancerous cells in the tumor microenvironment.  Consequently, therapeutics targeting the PI3K pathway are being developed at a rapid pace, and preclin. and early clin. studies are beginning to suggest specific strategies to effectively use them.  However, the central role of PI3K signaling in a large array of diverse biol. processes raises concerns about its use in therapeutics and increases the need to develop sophisticated strategies for its use.  In this review, we will discuss how PI3K signaling affects the growth and survival of tumor cells.  From this vantage, we will consider how inhibitors of the PI3K signaling cascade, either alone or in combination with other therapeutics, can most effectively be used for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPqtk2bVl0rVg90H21EOLACvtfcHk0ljc8RzwQOgrKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D&md5=b88b394919647e2eb47e7735355fde2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.3641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.3641%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DRyan%26aufirst%3DB.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520PI3K%2520pathway%2520as%2520a%2520drug%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1075%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Navigating downstream of AKT</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=Navigating+downstream+of+AKT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DNavigating%2520downstream%2520of%2520AKT%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bozulic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">PIKKing on PKB: Regulation of PKB activity by phosphorylation</span> <span class="citation_source-journal">Curr. Opin Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1016%2Fj.ceb.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19303758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=256-261&author=L.+Bozulicauthor=B.+A.+Hemmings&title=PIKKing+on+PKB%3A+Regulation+of+PKB+activity+by+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing on PKB: regulation of PKB activity by phosphorylation</span></div><div class="casAuthors">Bozulic, Lana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-261</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B (PKB)/Akt kinase is a key regulator of a wide range of cellular processes including growth, proliferation and survival.  PKB is clearly a crucial signaling mol. and extensive research efforts aim to understand its regulation and action.  Recent studies of the regulation of PKB activity by hydrophobic motif phosphorylation have yielded several exciting findings about members of the phosphatidylinositol 3-kinase (PI3K)-like family of kinases (PIKKs) acting as PKB regulators.  Mammalian target of rapamycin complex 2 (mTORC2) and DNA-dependent protein kinase (DNA-PK) can both phosphorylate Ser-473 and activate PKB.  This review concerns PKB regulation by mTORC2 and DNA-PK in a stimulus-dependent and context-dependent manner and the possible implications of this for PKB activity, substrate specificity, and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDTdYbqJWtLVg90H21EOLACvtfcHk0ljA8V8pWdTlYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D&md5=0b7a3e6ea561f8479701a01133b5d30c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBozulic%26aufirst%3DL.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPIKKing%2520on%2520PKB%253A%2520Regulation%2520of%2520PKB%2520activity%2520by%2520phosphorylation%26jtitle%3DCurr.%2520Opin%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1126%2Fscience.1106148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=15718470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1098-1101&author=D.+D.+Sarbassovauthor=D.+A.+Guertinauthor=S.+M.+Aliauthor=D.+M.+Sabatini&title=Phosphorylation+and+regulation+of+Akt%2FPKB+by+the+rictor-mTOR+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</span></div><div class="casAuthors">Sarbassov, Dos D.; Guertin, David A.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5712</span>),
    <span class="NLM_cas:pages">1098-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes.  Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.  We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its assocd. protein rictor are necessary for Ser473 phosphorylation and that a redn. in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector.  The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser473 in vitro and facilitated Thr308 phosphorylation by PDK1.  Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO1KyVE3glrVg90H21EOLACvtfcHk0lij3zf5wiTm1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D&md5=de758fd8128561e34301e67a42ae13a6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106148%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DPhosphorylation%2520and%2520regulation%2520of%2520Akt%252FPKB%2520by%2520the%2520rictor-mTOR%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1098%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Pierce, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The nuts and bolts of AGC protein kinases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnrm2822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20027184" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=9-22&author=L.+R.+Pierceauthor=D.+Komanderauthor=D.+R.+Alessi&title=The+nuts+and+bolts+of+AGC+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm2822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2822%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DL.%2BR.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520nuts%2520and%2520bolts%2520of%2520AGC%2520protein%2520kinases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mattmann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Inhibition of Akt with small molecules and biologics: Historical perspective and current status of the patent landscape</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1517%2F13543776.2011.587959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=21635152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1309-1338&issue=9&author=M.+E.+Mattmannauthor=S.+L.+Stoopsauthor=C.+W.+Lindsley&title=Inhibition+of+Akt+with+small+molecules+and+biologics%3A+Historical+perspective+and+current+status+of+the+patent+landscape"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape</span></div><div class="casAuthors">Mattmann, Margrith E.; Stoops, Sydney L.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1309-1338</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors; unregulated activation of the PI3K/PTEN/Akt pathway is a prominent feature of many human cancers.  Akt is considered an attractive target for cancer therapy by the inhibition of Akt alone or in combination with std. cancer chemotherapeutics.  Both preclin. animal studies and clin. trials in humans have validated Akt as an important target of cancer drug discovery.Area covered: A historical perspective of Akt inhibitors, including PI analogs, ATP-competitive and allosteric Akt inhibitors, along with other inhibitory mechanisms are reviewed in this paper with a focus on issued patents, patent applications and a summary of clin. trial updates since the last review in 2007.Expert opinion: A vast diversity of inhibitors of Akt, both small mol. and biol., have been developed in the past 5 years, with over a dozen in various phases of clin. development, and several displaying efficacy in humans.  While it is not yet clear which mechanism of Akt inhibition will be optimal in humans, or which Akt isoforms to inhibit, or whether a small mol. or biol. agent will be best, data to all of these points will be available in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByLgyoYrIULVg90H21EOLACvtfcHk0lizswNge2G4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfM&md5=292eeb3e83a0a8aaa3fea0cb8df7d83d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.587959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.587959%26sid%3Dliteratum%253Aachs%26aulast%3DMattmann%26aufirst%3DM.%2BE.%26aulast%3DStoops%26aufirst%3DS.%2BL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520Akt%2520with%2520small%2520molecules%2520and%2520biologics%253A%2520Historical%2520perspective%2520and%2520current%2520status%2520of%2520the%2520patent%2520landscape%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26issue%3D9%26spage%3D1309%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Meuillet, E. J.</span><span> </span><span class="NLM_article-title">Novel inhibitors of AKT: Assessment of a different approach targeting the pleckstrin homology domain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2727</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.2174%2F092986711796011292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=21649580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2727-2742&author=E.+J.+Meuillet&title=Novel+inhibitors+of+AKT%3A+Assessment+of+a+different+approach+targeting+the+pleckstrin+homology+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain</span></div><div class="casAuthors">Meuillet, E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2727-2742</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B/AKT plays a central role in cancer.  The Ser/Thr kinase is over-expressed or constitutively active in many cancers and was validated as a therapeutic target for cancer treatment.  However, targeting the kinase activity has revealed itself to be a challenge due to non-selectivity of the compds. towards other kinases.  This review summarizes other approaches scientists have developed to inhibit the activity and function of AKT.  They consist of targeting the pleckstrin homol. (PH) domain of AKT.  Indeed, upon the generation of 3-phosphorylated phosphatidylinositol phosphates (PI3Ps) by PI3-kinase (PI3K), AKT translocates from the cytosol to the plasma membrane and binds to the PI3Ps via its PH domain.  Thus, several analogs of PI3Ps (PI Analogs or PIAs), alkylphospholipids (APLs), such as edelfosine, and inositol phosphates (IPs) have been described that inhibit the binding of the PH domain to PI3Ps.  Recently allosteric inhibitors and small mols. that do not bind the kinase domain but affect the kinase activity of AKT, presumably by interacting with the PH domain, were also identified.  Finally, several drug screening studies spawned novel chem. scaffolds that bind the PH domain of AKT.  Together, these approaches were more or less successful in vitro and to some extent translated in preclin. studies.  Several of these new AKT PH domain inhibitors exhibit promising anti-tumor activity in mouse models and some of them show synergy with ionizing radiation and chemotherapy.  Early clin. trials have started and results will attest to the validity and efficacy of such approaches in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquNQ7fkejNPbVg90H21EOLACvtfcHk0lizswNge2G4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73O&md5=ff82a5abce3e67670681942e6af0ba19</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986711796011292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011292%26sid%3Dliteratum%253Aachs%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26atitle%3DNovel%2520inhibitors%2520of%2520AKT%253A%2520Assessment%2520of%2520a%2520different%2520approach%2520targeting%2520the%2520pleckstrin%2520homology%2520domain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2727%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Okuzumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Inhibitor hijacking of Akt activation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnchembio.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19465931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=484-493&author=T.+Okuzumiauthor=D.+Fiedlerauthor=C.+Zhangauthor=D.+C.+Grayauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=K.+M.+Shokat&title=Inhibitor+hijacking+of+Akt+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor hijacking of Akt activation</span></div><div class="casAuthors">Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Gray, Daniel C.; Aizenstein, Brian; Hoffman, Randy; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">484-493</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase Akt plays a central role as a regulator of multiple growth factor input signals, thus making it an attractive anticancer drug target.  A-443654 is an ATP-competitive Akt inhibitor.  Unexpectedly, treatment of cells with A-443654 causes paradoxical hyperphosphorylation of Akt at its two regulatory sites (Thr308 and Ser473).  We explored whether inhibitor-induced hyperphosphorylation of Akt by A-443654 is a consequence of disrupted feedback regulation at a pathway level or whether it is a direct consequence of inhibitor binding to the ATP binding site of Akt.  Catalytically inactive mutants of Akt revealed that binding of an inhibitor to the ATP site of Akt is sufficient to directly cause hyperphosphorylation of the kinase in the absence of any pathway feedback effects.  We conclude that ATP-competitive Akt inhibitors impart regulatory phosphorylation of their target kinase Akt.  These results provide new insights into both natural regulation of Akt activation and Akt inhibitors entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNjUB9YVue7Vg90H21EOLACvtfcHk0lizswNge2G4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D&md5=4edb5a0457fd9378850102a6414bfdb5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.183%26sid%3Dliteratum%253Aachs%26aulast%3DOkuzumi%26aufirst%3DT.%26aulast%3DFiedler%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DD.%2BC.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DInhibitor%2520hijacking%2520of%2520Akt%2520activation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sootome, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span> </span><span class="NLM_article-title">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1158%2F1535-7163.MCT-09-1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20571069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1956-1967&issue=7&author=H.+Hiraiauthor=H.+Sootomeauthor=Y.+Nakatsuruauthor=K.+Miyamaauthor=S.+Taguchiauthor=K.+Tsujiokaauthor=Y.+Uenoauthor=H.+Hatchauthor=P.+K.+Majumderauthor=B.-S.+Panauthor=H.+Kotani&title=MK-2206%2C+an+allosteric+Akt+inhibitor%2C+enhances+antitumor+efficacy+by+standard+chemotherapeutic+agents+or+molecular+targeted+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span></div><div class="casAuthors">Hirai, Hiroshi; Sootome, Hiroshi; Nakatsuru, Yoko; Miyama, Katsuyoshi; Taguchi, Shunsuke; Tsujioka, Kyoko; Ueno, Yoko; Hatch, Harold; Majumder, Pradip K.; Pan, Bo-Sheng; Kotani, Hidehito</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt lies at a crit. signaling node downstream of phosphatidylinositol-3-kinase and is important in promoting cell survival and inhibiting apoptosis.  An Akt inhibitor may be particularly useful for cancers in which increased Akt signaling is assocd. with reduced sensitivity to cytotoxic agents or receptor tyrosine kinase inhibitors.  We evaluated the effect of a novel allosteric Akt inhibitor, MK-2206, in combination with several anticancer agents.  In vitro, MK-2206 synergistically inhibited cell proliferation of human cancer cell lines in combination with mol. targeted agents such as erlotinib (an epidermal growth factor receptor inhibitor) or lapatinib (a dual epidermal growth factor receptor/human epidermal growth factor receptor 2 inhibitor).  Complementary inhibition of erlotinib-insensitive Akt phosphorylation by MK-2206 was one mechanism of synergism, and a synergistic effect was found even in erlotinib-insensitive cell lines.  MK-2206 also showed synergistic responses in combination with cytotoxic agents such as topoisomerase inhibitors (doxorubicin, camptothecin), antimetabolites (gemcitabine, 5-fluorouracil), anti-microtubule agents (docetaxel), and DNA cross-linkers (carboplatin) in lung NCI-H460 or ovarian A2780 tumor cells.  The synergy with docetaxel depended on the treatment sequence; a schedule of MK-2206 dosed before docetaxel was not effective.  MK-2206 suppressed the Akt phosphorylation that is induced by carboplatin and gemcitabine.  In vivo, MK-2206 in combination with these agents exerted significantly more potent tumor inhibitory activities than each agent in the monotherapy setting.  These findings suggest that Akt inhibition may augment the efficacy of existing cancer therapeutics; thus, MK-2206 is a promising agent to treat cancer patients who receive these cytotoxic and/or mol. targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgnWgk1SeALVg90H21EOLACvtfcHk0lgKghiFO-OYOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL&md5=f2d97ab64963cc82d97b35697e49b172</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1012%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSootome%26aufirst%3DH.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMiyama%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DS.%26aulast%3DTsujioka%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DMajumder%26aufirst%3DP.%2BK.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKotani%26aufirst%3DH.%26atitle%3DMK-2206%252C%2520an%2520allosteric%2520Akt%2520inhibitor%252C%2520enhances%2520antitumor%2520efficacy%2520by%2520standard%2520chemotherapeutic%2520agents%2520or%2520molecular%2520targeted%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D7%26spage%3D1956%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mitchell, I. S.; Blake, J. F.; Xu, R.; Kallan, N. C.; Xiao, D.; Spencer, K. L.; Bencsik, J. R.; Liang, J.; Safina, B.; Zhang, B.; Chabot, C.; Do, S.</span><span> </span><span class="NLM_article-title">Preparation of cyclopenta[<i>d</i>]pyrimidine derivatives as Akt protein kinase inhibitors</span>. PCT Int. Appl. WO2008006040,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+S.+Mitchell&author=J.+F.+Blake&author=R.+Xu&author=N.+C.+Kallan&author=D.+Xiao&author=K.+L.+Spencer&author=J.+R.+Bencsik&author=J.+Liang&author=B.+Safina&author=B.+Zhang&author=C.+Chabot&author=S.+Do&title=Preparation+of+cyclopenta%5Bd%5Dpyrimidine+derivatives+as+Akt+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DI.%2BS.%26atitle%3DPreparation%2520of%2520cyclopenta%255Bd%255Dpyrimidine%2520derivatives%2520as%2520Akt%2520protein%2520kinase%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pal, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reckamp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figlin, R. A.</span><span> </span><span class="NLM_article-title">Akt inhibitors in clinical development for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1355-1366&issue=11&author=S.+K.+Palauthor=K.+Reckampauthor=H.+Yuauthor=R.+A.+Figlin&title=Akt+inhibitors+in+clinical+development+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%2BK.%26aulast%3DReckamp%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26atitle%3DAkt%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26issue%3D11%26spage%3D1355%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Johnson, P. D.; Leach, A.; Luke, R. W. A.; Matusiak, Z. S.; Morris, J. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolo[2,3-<i>d</i>]pyrimidine derivatives as protein kinase B inhibitors</span>. WO2009047563.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johnson%2C+P.+D.%3B+Leach%2C+A.%3B+Luke%2C+R.+W.+A.%3B+Matusiak%2C+Z.+S.%3B+Morris%2C+J.+J.+Preparation+of+pyrrolo%5B2%2C3-d%5Dpyrimidine+derivatives+as+protein+kinase+B+inhibitors.+WO2009047563."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%2520pyrrolo%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520protein%2520kinase%2520B%2520inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-<i>f</i>][1,6]naphthyridines with potent and balanced activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=834-836&issue=3&author=Y.+Liauthor=J.+Liangauthor=T+Siuauthor=E.+Huauthor=M.+A.+Rossiauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=R.+G.+Robinsonauthor=K.+Leanderauthor=H.+E.+Huberauthor=S.+Mittalauthor=N.+Cosfordauthor=P.+Prasit&title=Allosteric+inhibitors+of+Akt1+and+Akt2%3A+Discovery+of+%5B1%2C2%2C4%5Dtriazolo%5B3%2C4-f%5D%5B1%2C6%5Dnaphthyridines+with+potent+and+balanced+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DT%26aulast%3DHu%26aufirst%3DE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DLeander%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DCosford%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DAllosteric%2520inhibitors%2520of%2520Akt1%2520and%2520Akt2%253A%2520Discovery%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B3%252C4-f%255D%255B1%252C6%255Dnaphthyridines%2520with%2520potent%2520and%2520balanced%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D834%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Development of pyridopyrimidines as potent Akt1/2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1274-1279&issue=4&author=Z.+Wuauthor=J.+C.+Hartnettauthor=L.+A.+Neilsonauthor=R.+G.+Robinsonauthor=S.+Fuauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=A.+M.+Kralauthor=H.+E.+Huberauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Development+of+pyridopyrimidines+as+potent+Akt1%2F2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHartnett%26aufirst%3DJ.%2BC.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DDevelopment%2520of%2520pyridopyrimidines%2520as%2520potent%2520Akt1%252F2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D4%26spage%3D1274%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Allosteric Akt (PKB) inhibitors: Discovery and SAR of isozyme selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=761-764&issue=3&author=C.+W.+Lindsleyauthor=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Duggan&title=Allosteric+Akt+%28PKB%29+inhibitors%3A+Discovery+and+SAR+of+isozyme+selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DAllosteric%2520Akt%2520%2528PKB%2529%2520inhibitors%253A%2520Discovery%2520and%2520SAR%2520of%2520isozyme%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D3%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wu, W.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voegtli, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dizon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J</span><span> </span><span class="NLM_article-title">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e12913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e12913&issue=9&author=W.-I.+Wuauthor=W.+C.+Voegtliauthor=H.+L.+Sturgisauthor=F.+P.+Dizonauthor=G+Vigersauthor=B.+J+Brandhuber&title=Crystal+structure+of+human+AKT1+with+an+allosteric+inhibitor+reveals+a+new+mode+of+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-I.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DDizon%26aufirst%3DF.%2BP.%26aulast%3DVigers%26aufirst%3DG%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ%26atitle%3DCrystal%2520structure%2520of%2520human%2520AKT1%2520with%2520an%2520allosteric%2520inhibitor%2520reveals%2520a%2520new%2520mode%2520of%2520kinase%2520inhibition%26jtitle%3DPLoS%2520ONE%26date%3D2010%26volume%3D5%26issue%3D9%26spage%3De12913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Discovery of brivanib alaninate ((<i>S</i>)-((<i>R</i>)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1976</span><span class="NLM_x">–</span> <span class="NLM_lpage">1980</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7013309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1976-1980&issue=6&author=Z.-W.+Caiauthor=Y.+Zhangauthor=R.+M.+Borzilleriauthor=L.+Qianauthor=S.+Barbosaauthor=D.+Weiauthor=X.+Zhengauthor=L.+Wuauthor=J.+Fanauthor=Z.+Shiauthor=B.+S.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+W.+Kukralauthor=A.+Kamathauthor=P.+Maratheauthor=C.+D%E2%80%99Arienzoauthor=G.+Derbinauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+S.+Bhide&title=Discovery+of+brivanib+alaninate+%28%28S%29-%28%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propan-2-yl%292-aminopropanoate%29%2C+a+novel+prodrug+of+dual+vascular+endothelial+growth+factor+receptor-2+and+fibroblast+growth+factor+receptor-1+kinase+inhibitor+%28BMS-540215%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm7013309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7013309%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DDiscovery%2520of%2520brivanib%2520alaninate%2520%2528%2528S%2529-%2528%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-2-yl%25292-aminopropanoate%2529%252C%2520a%2520novel%2520prodrug%2520of%2520dual%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520and%2520fibroblast%2520growth%2520factor%2520receptor-1%2520kinase%2520inhibitor%2520%2528BMS-540215%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D6%26spage%3D1976%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hoelder, S.; Zuelch, A.; Baer, T.; Maier, T.; Zimmermann, A.; Beckers, T.; Gekeler, V.; Joshi, H.; Munot, Y.; Bhise, U.; Chavan, S.; Shivatare, S.; Patel, S.; Gore, V.</span><span> </span><span class="NLM_article-title">Preparation of fused imidazoles for cancer treatment</span>. PCT Int. Appl. WO2009021990,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Hoelder&author=A.+Zuelch&author=T.+Baer&author=T.+Maier&author=A.+Zimmermann&author=T.+Beckers&author=V.+Gekeler&author=H.+Joshi&author=Y.+Munot&author=U.+Bhise&author=S.+Chavan&author=S.+Shivatare&author=S.+Patel&author=V.+Gore&title=Preparation+of+fused+imidazoles+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520fused%2520imidazoles%2520for%2520cancer%2520treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=905-909&issue=4&author=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Dugganauthor=C.+W.+Lindsley&title=Discovery+of+2%2C3%2C5-trisubstituted+pyridine+derivatives+as+potent+Akt1+and+Akt2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%25202%252C3%252C5-trisubstituted%2520pyridine%2520derivatives%2520as%2520potent%2520Akt1%2520and%2520Akt2%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D4%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized isoquinolines via sequential cyclization/cross-coupling reactions</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc900079s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWktb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=895-899&issue=5&author=X.+Yuauthor=J.+Wu&title=Synthesis+of+functionalized+isoquinolines+via+sequential+cyclization%2Fcross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Functionalized Isoquinolines via Sequential Cyclization/Cross-Coupling Reactions</span></div><div class="casAuthors">Yu, Xingxin; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">895-899</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CuX2-mediated cyclization of 2-alkynylbenzaldehyde O-Me oximes in N,N-dimethylacetamide (DMA) gave rise to 4-chloroisoquinolines, e.g. I (X = Cl), in good yield, which underwent the palladium-catalyzed cross-coupling reactions of arylboronic acids subsequently to afford the functionalized isoquinolines, e.g. I (X = Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOetzxg_l4prVg90H21EOLACvtfcHk0liyuF8e8d63_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWktb3E&md5=95382c64c669dff9a9b9945224b2bc91</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcc900079s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc900079s%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520functionalized%2520isoquinolines%2520via%2520sequential%2520cyclization%252Fcross-coupling%2520reactions%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26issue%3D5%26spage%3D895%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hartnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span> </span><span class="NLM_article-title">Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2194-2197&issue=6&author=J.+C.+Hartnettauthor=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=D.+Defeo-Jonesauthor=G.+D.+Hartmanauthor=H.+E.+Huberauthor=R.+E.+Jonesauthor=A.+M.+Kralauthor=R.+G.+Robinsonauthor=Z.+Wu&title=Optimization+of+2%2C3%2C5-trisubstituted+pyridine+derivatives+as+potent+allosteric+Akt1+and+Akt2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartnett%26aufirst%3DJ.%2BC.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DOptimization%2520of%25202%252C3%252C5-trisubstituted%2520pyridine%2520derivatives%2520as%2520potent%2520allosteric%2520Akt1%2520and%2520Akt2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D2194%26epage%3D2197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>Maestro, version 9.2; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>Glide, version 5.7; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sohlenius-Sternbeck, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afzelius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogstraate, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gissberg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, C.</span><span> </span><span class="NLM_article-title">Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=637-649&author=A.-K.+Sohlenius-Sternbeckauthor=L.+Afzeliusauthor=P.+Prusisauthor=J.+Neelissenauthor=J.+Hoogstraateauthor=J.+Johanssonauthor=E.+Flobyauthor=A.+Bengtssonauthor=O.+Gissbergauthor=J.+Sternbeckauthor=C.+Petersson&title=Evaluation+of+the+human+prediction+of+clearance+from+hepatocyte+and+microsome+intrinsic+clearance+for+52+drug+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSohlenius-Sternbeck%26aufirst%3DA.-K.%26aulast%3DAfzelius%26aufirst%3DL.%26aulast%3DPrusis%26aufirst%3DP.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DHoogstraate%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DFloby%26aufirst%3DE.%26aulast%3DBengtsson%26aufirst%3DA.%26aulast%3DGissberg%26aufirst%3DO.%26aulast%3DSternbeck%26aufirst%3DJ.%26aulast%3DPetersson%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520the%2520human%2520prediction%2520of%2520clearance%2520from%2520hepatocyte%2520and%2520microsome%2520intrinsic%2520clearance%2520for%252052%2520drug%2520compounds%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D637%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ashwell, M. A.; Brassard, C.; Filikov, A.; Hill, J.; Koerner, S.; Lapierre, J.-M.; Liu, Y.; Namdev, N.; Nicewonger, R.; Palma, R.; Tandon, M.; Vensel, D.; Matsuda, A.; Iimura, S.; Yamamoto, Y.</span><span> </span><span class="NLM_article-title">Preparation of substituted imidazopyridinyl-aminopyridine compounds as antitumor agents</span>. PCT Int. Appl. WO2011082270,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+A.+Ashwell&author=C.+Brassard&author=A.+Filikov&author=J.+Hill&author=S.+Koerner&author=J.-M.+Lapierre&author=Y.+Liu&author=N.+Namdev&author=R.+Nicewonger&author=R.+Palma&author=M.+Tandon&author=D.+Vensel&author=A.+Matsuda&author=S.+Iimura&author=Y.+Yamamoto&title=Preparation+of+substituted+imidazopyridinyl-aminopyridine+compounds+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520substituted%2520imidazopyridinyl-aminopyridine%2520compounds%2520as%2520antitumor%2520agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bell, M. P.; O’Dowd, C. R.; Rountree, J. S. S.; Trevitt, G. P.; Harrison, T.; McFarland, M. M..</span><span> </span><span class="NLM_article-title">Preparation of furopyrimidine and furopyridine derivatives as AKT/PKB inhibitors</span>. PCT Int. Appl. WO2011055115,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+P.+Bell&author=C.+R.+O%E2%80%99Dowd&author=J.+S.+S.+Rountree&author=G.+P.+Trevitt&author=T.+Harrison&author=M.+M..+McFarland&title=Preparation+of+furopyrimidine+and+furopyridine+derivatives+as+AKT%2FPKB+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%2520furopyrimidine%2520and%2520furopyridine%2520derivatives%2520as%2520AKT%252FPKB%2520inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bell, M. P.; O’Dowd, C. R.; Zhang, L.; Tevitt, G. P.; Harrison, T.; Battacharyya, S.; Rountree, J. S. S.; Burkamp, F.; Price, S.; Macleod, C.; Elliott, R. L.; Smith, P.; Blench, T. J.; Dyke, H. J.</span><span> </span><span class="NLM_article-title">Preparation of chromen-4-one, pyrano[2,3-<i>c</i>]pyridin-4-one, and 7<i>H</i>-pyrano[2,3-<i>e</i>]indazol-4-one derivatives as anticancer agents</span>. PCT Int. Appl.  WO2011033265,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+P.+Bell&author=C.+R.+O%E2%80%99Dowd&author=L.+Zhang&author=G.+P.+Tevitt&author=T.+Harrison&author=S.+Battacharyya&author=J.+S.+S.+Rountree&author=F.+Burkamp&author=S.+Price&author=C.+Macleod&author=R.+L.+Elliott&author=P.+Smith&author=T.+J.+Blench&author=H.+J.+Dyke&title=Preparation+of+chromen-4-one%2C+pyrano%5B2%2C3-c%5Dpyridin-4-one%2C+and+7H-pyrano%5B2%2C3-e%5Dindazol-4-one+derivatives+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%2520chromen-4-one%252C%2520pyrano%255B2%252C3-c%255Dpyridin-4-one%252C%2520and%25207H-pyrano%255B2%252C3-e%255Dindazol-4-one%2520derivatives%2520as%2520anticancer%2520agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Moritz Balkenhohl, Bruno Salgues, Takahiro Hirai, Konstantin Karaghiosoff, <span class="NLM_string-name hlFld-ContribAuthor">Paul Knochel</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Metalation and Functionalization of the Pyrazolo[1,5-a]pyridine Scaffold Using Mg- and Zn-TMP Bases. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (10)
                                     , 3114-3118. <a href="https://doi.org/10.1021/acs.orglett.8b01204" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01204%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegioselective%252BMetalation%252Band%252BFunctionalization%252Bof%252Bthe%252BPyrazolo%25255B1%25252C5-a%25255Dpyridine%252BScaffold%252BUsing%252BMg-%252Band%252BZn-TMP%252BBases%26aulast%3DBalkenhohl%26aufirst%3DMoritz%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16042018%26date%3D08052018%26volume%3D20%26issue%3D10%26spage%3D3114%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Mu</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Dapeng  Zou</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>, and <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Pd-Catalyzed Tandem Cyclization via C–H Arylation and Acylation for the Construction of Polycyclic Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (20)
                                     , 5260-5263. <a href="https://doi.org/10.1021/acs.orglett.6b02571" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b02571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b02571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b02571%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPd-Catalyzed%252BTandem%252BCyclization%252Bvia%252BC%2525E2%252580%252593H%252BArylation%252Band%252BAcylation%252Bfor%252Bthe%252BConstruction%252Bof%252BPolycyclic%252BScaffolds%26aulast%3DMu%26aufirst%3DBing%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28082016%26date%3D04102016%26date%3D21102016%26volume%3D18%26issue%3D20%26spage%3D5260%26epage%3D5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongwen  Li</span>, <span class="hlFld-ContribAuthor ">Jianyu  Dong</span>, <span class="hlFld-ContribAuthor ">Xiuling  Chen</span>, <span class="hlFld-ContribAuthor ">Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Yongbo  Zhou</span>, and <span class="hlFld-ContribAuthor ">Shuang-Feng  Yin</span>  . </span><span class="cited-content_cbyCitation_article-title">Metal- and Oxidant-Free Synthesis of Quinazolinones from β-Ketoesters with o-Aminobenzamides via Phosphorous Acid-Catalyzed Cyclocondensation and Selective C–C Bond Cleavage. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (19)
                                     , 9392-9400. <a href="https://doi.org/10.1021/acs.joc.5b00937" title="DOI URL">https://doi.org/10.1021/acs.joc.5b00937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b00937%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-%252Band%252BOxidant-Free%252BSynthesis%252Bof%252BQuinazolinones%252Bfrom%252B%2525CE%2525B2-Ketoesters%252Bwith%252Bo-Aminobenzamides%252Bvia%252BPhosphorous%252BAcid-Catalyzed%252BCyclocondensation%252Band%252BSelective%252BC%2525E2%252580%252593C%252BBond%252BCleavage%26aulast%3DLi%26aufirst%3DZhongwen%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26042015%26date%3D11092015%26date%3D02102015%26date%3D04092015%26volume%3D80%26issue%3D19%26spage%3D9392%26epage%3D9400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinsheng  Xiao</span>, <span class="hlFld-ContribAuthor ">Ying  Xie</span>, <span class="hlFld-ContribAuthor ">Siyi  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanfu  Deng</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>, and <span class="hlFld-ContribAuthor ">Wei  Zeng</span>  . </span><span class="cited-content_cbyCitation_article-title">Transition-Metal-Free Tandem Chlorocyclization of Amines with Carboxylic Acids: Access to Chloroimidazo[1,2-α]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (16)
                                     , 3998-4001. <a href="https://doi.org/10.1021/acs.orglett.5b01868" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01868%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTransition-Metal-Free%252BTandem%252BChlorocyclization%252Bof%252BAmines%252Bwith%252BCarboxylic%252BAcids%25253A%252BAccess%252Bto%252BChloroimidazo%25255B1%25252C2-%2525CE%2525B1%25255Dpyridines%26aulast%3DXiao%26aufirst%3DXinsheng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D29062015%26date%3D31072015%26date%3D21082015%26volume%3D17%26issue%3D16%26spage%3D3998%26epage%3D4001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>, <span class="hlFld-ContribAuthor ">Brendan  Frett</span>, and <span class="hlFld-ContribAuthor ">Hong-yu  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Access to 2,3-Diarylimidazo[1,2-a]pyridines via a One-Pot, Ligand-Free, Palladium-Catalyzed Three-Component Reaction under Microwave Irradiation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2014,</strong> <em>16 </em>
                                    (11)
                                     , 3016-3019. <a href="https://doi.org/10.1021/ol501136e" title="DOI URL">https://doi.org/10.1021/ol501136e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol501136e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol501136e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BAccess%252Bto%252B2%25252C3-Diarylimidazo%25255B1%25252C2-a%25255Dpyridines%252Bvia%252Ba%252BOne-Pot%25252C%252BLigand-Free%25252C%252BPalladium-Catalyzed%252BThree-Component%252BReaction%252Bunder%252BMicrowave%252BIrradiation%26aulast%3DWang%26aufirst%3DYuanxiang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19042014%26date%3D22052014%26date%3D06062014%26volume%3D16%26issue%3D11%26spage%3D3016%26epage%3D3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Gerasi</span>, <span class="hlFld-ContribAuthor ">Efseveia  Frakolaki</span>, <span class="hlFld-ContribAuthor ">Georgios  Papadakis</span>, <span class="hlFld-ContribAuthor ">Anna  Chalari</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Lougiakis</span>, <span class="hlFld-ContribAuthor ">Panagiotis  Marakos</span>, <span class="hlFld-ContribAuthor ">Nicole  Pouli</span>, <span class="hlFld-ContribAuthor ">Niki  Vassilaki</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103580. <a href="https://doi.org/10.1016/j.bioorg.2020.103580" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103580%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-HBV%252Bactivity%252Bevaluation%252Bof%252Bnew%252Bsubstituted%252Bimidazo%25255B4%25252C5-b%25255Dpyridines%26aulast%3DGerasi%26aufirst%3DMaria%26date%3D2020%26volume%3D98%26spage%3D103580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranin  Kawtharani</span>, <span class="hlFld-ContribAuthor ">Khalil  Cherry</span>, <span class="hlFld-ContribAuthor ">Mirvat  Elmasri</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">An Easy Access to 4‐Trifluoromethylated 7‐(4‐Substitued‐1
              H
              ‐1,2,3‐Triazol‐1‐yl)Pyrimido[1,2‐
              b
              ]Pyridazin‐2‐One Systems. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (38)
                                     , 11222-11226. <a href="https://doi.org/10.1002/slct.201902375" title="DOI URL">https://doi.org/10.1002/slct.201902375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201902375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201902375%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAn%252BEasy%252BAccess%252Bto%252B4%2525E2%252580%252590Trifluoromethylated%252B7%2525E2%252580%252590%2525284%2525E2%252580%252590Substitued%2525E2%252580%2525901%252BH%252B%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590Triazol%2525E2%252580%2525901%2525E2%252580%252590yl%252529Pyrimido%25255B1%25252C2%2525E2%252580%252590%252Bb%252B%25255DPyridazin%2525E2%252580%2525902%2525E2%252580%252590One%252BSystems%26aulast%3DKawtharani%26aufirst%3DRanin%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D38%26spage%3D11222%26epage%3D11226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praewpan  Katrun</span>, <span class="hlFld-ContribAuthor ">Chutima  Kuhakarn</span>. </span><span class="cited-content_cbyCitation_article-title">K2S2O8-Mediated halogenation of 2-arylimidazo[1,2-a]pyridines using sodium halides as the halogen sources. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (14)
                                     , 989-993. <a href="https://doi.org/10.1016/j.tetlet.2019.03.008" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DK2S2O8-Mediated%252Bhalogenation%252Bof%252B2-arylimidazo%25255B1%25252C2-a%25255Dpyridines%252Busing%252Bsodium%252Bhalides%252Bas%252Bthe%252Bhalogen%252Bsources%26aulast%3DKatrun%26aufirst%3DPraewpan%26date%3D2019%26volume%3D60%26issue%3D14%26spage%3D989%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuejing  Liu</span>, <span class="hlFld-ContribAuthor ">Han  Cao</span>, <span class="hlFld-ContribAuthor ">Fusheng  Bie</span>, <span class="hlFld-ContribAuthor ">Peng  Yan</span>, <span class="hlFld-ContribAuthor ">Ying  Han</span>. </span><span class="cited-content_cbyCitation_article-title">C N bond formation and cyclization: A straightforward and metal-free synthesis of N-1-alkyl-2-unsubstituted benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (15)
                                     , 1057-1059. <a href="https://doi.org/10.1016/j.tetlet.2019.03.028" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.03.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.03.028%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DC%252BN%252Bbond%252Bformation%252Band%252Bcyclization%25253A%252BA%252Bstraightforward%252Band%252Bmetal-free%252Bsynthesis%252Bof%252BN-1-alkyl-2-unsubstituted%252Bbenzimidazoles%26aulast%3DLiu%26aufirst%3DXuejing%26date%3D2019%26volume%3D60%26issue%3D15%26spage%3D1057%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianglong  Chu</span>, <span class="hlFld-ContribAuthor ">Zeyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Congcong  Wang</span>, <span class="hlFld-ContribAuthor ">Xuan  Chen</span>, <span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">CH3CO2H-prompted three components tandem reaction: An efficient and practical approach to trisubstituted pyrrolo[1,2-a]pyrazines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (51)
                                     , 7185-7189. <a href="https://doi.org/10.1016/j.tet.2017.10.066" title="DOI URL">https://doi.org/10.1016/j.tet.2017.10.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.10.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCH3CO2H-prompted%252Bthree%252Bcomponents%252Btandem%252Breaction%25253A%252BAn%252Befficient%252Band%252Bpractical%252Bapproach%252Bto%252Btrisubstituted%252Bpyrrolo%25255B1%25252C2-a%25255Dpyrazines%26aulast%3DChu%26aufirst%3DXianglong%26date%3D2017%26volume%3D73%26issue%3D51%26spage%3D7185%26epage%3D7189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn  Johnstone</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (11)
                                     , 2239-2258. <a href="https://doi.org/10.1016/j.bmcl.2017.03.084" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.084%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPharmacological%252Bproperty%252Boptimization%252Bfor%252Ballosteric%252Bligands%25253A%252BA%252Bmedicinal%252Bchemistry%252Bperspective%26aulast%3DJohnstone%26aufirst%3DShawn%26date%3D2017%26volume%3D27%26issue%3D11%26spage%3D2239%26epage%3D2258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuka  Morioka</span>, <span class="hlFld-ContribAuthor ">Jin-Min  Nam</span>, <span class="hlFld-ContribAuthor ">Takashi  Ohashi</span>, . </span><span class="cited-content_cbyCitation_article-title">Nik-related kinase regulates trophoblast proliferation and placental development by modulating AKT phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2017,</strong> <em>12 </em>
                                    (2)
                                     , e0171503. <a href="https://doi.org/10.1371/journal.pone.0171503" title="DOI URL">https://doi.org/10.1371/journal.pone.0171503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0171503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0171503%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DNik-related%252Bkinase%252Bregulates%252Btrophoblast%252Bproliferation%252Band%252Bplacental%252Bdevelopment%252Bby%252Bmodulating%252BAKT%252Bphosphorylation%26aulast%3DMorioka%26aufirst%3DYuka%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D2%26spage%3De0171503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz P. Fernandez  Diaz Ropero</span>, <span class="hlFld-ContribAuthor ">Mark R. J.  Elsegood</span>, <span class="hlFld-ContribAuthor ">Gary  Fairley</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Pritchard</span>, <span class="hlFld-ContribAuthor ">George W.  Weaver</span>. </span><span class="cited-content_cbyCitation_article-title">Pyridone Functionalization: Regioselective Deprotonation of 6-Methylpyridin-2(1
              H
              )- and -4(1
              H
              )-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (31)
                                     , 5238-5242. <a href="https://doi.org/10.1002/ejoc.201601156" title="DOI URL">https://doi.org/10.1002/ejoc.201601156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201601156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201601156%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPyridone%252BFunctionalization%25253A%252BRegioselective%252BDeprotonation%252Bof%252B6-Methylpyridin-2%2525281%252BH%252B%252529-%252Band%252B-4%2525281%252BH%252B%252529-one%252BDerivatives%26aulast%3DDiaz%2BRopero%26aufirst%3DBeatriz%2BP.%2BFernandez%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D31%26spage%3D5238%26epage%3D5242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayla  Hazrathoseyni</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Seyedi</span>, <span class="hlFld-ContribAuthor ">Hossein  Eshghi</span>, <span class="hlFld-ContribAuthor ">Ali  Shiri</span>, <span class="hlFld-ContribAuthor ">Mohammad  Saadatmandzadeh</span>, <span class="hlFld-ContribAuthor ">Ali Reza  Berenji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Docking Evaluations of New Derivatives of Pyrimido[4,5-
              c
              ]pyridazine as Potential Human AKT1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (1)
                                     , 135-143. <a href="https://doi.org/10.1002/jhet.2296" title="DOI URL">https://doi.org/10.1002/jhet.2296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BDocking%252BEvaluations%252Bof%252BNew%252BDerivatives%252Bof%252BPyrimido%25255B4%25252C5-%252Bc%252B%25255Dpyridazine%252Bas%252BPotential%252BHuman%252BAKT1%252BInhibitors%26aulast%3DHazrathoseyni%26aufirst%3DAyla%26date%3D2016%26date%3D2015%26volume%3D53%26issue%3D1%26spage%3D135%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Mu</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Dapeng  Zou</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>, <span class="hlFld-ContribAuthor ">Yangjie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">An unprecedented Pd-catalyzed decarboxylative coupling reaction of aromatic carboxylic acids in aqueous medium under air: synthesis of 3-aryl-imidazo[1,2-a]pyridines from aryl chlorides. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (1)
                                     , 246-250. <a href="https://doi.org/10.1039/C5OB02112J" title="DOI URL">https://doi.org/10.1039/C5OB02112J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB02112J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB02112J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Bunprecedented%252BPd-catalyzed%252Bdecarboxylative%252Bcoupling%252Breaction%252Bof%252Baromatic%252Bcarboxylic%252Bacids%252Bin%252Baqueous%252Bmedium%252Bunder%252Bair%25253A%252Bsynthesis%252Bof%252B3-aryl-imidazo%25255B1%25252C2-a%25255Dpyridines%252Bfrom%252Baryl%252Bchlorides%26aulast%3DMu%26aufirst%3DBing%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D1%26spage%3D246%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johan  J. N. Veerman</span>, <span class="hlFld-ContribAuthor ">Matthew  G. Bursavich</span>, <span class="hlFld-ContribAuthor ">Yorik  B. Bruseker</span>, <span class="hlFld-ContribAuthor ">Bart  C. J. van Esseveldt</span>, <span class="hlFld-ContribAuthor ">Rebecca  Glen</span>, <span class="hlFld-ContribAuthor ">Bryce  A. Harrison</span>, <span class="hlFld-ContribAuthor ">Erik  H. Heijne</span>, <span class="hlFld-ContribAuthor ">Andrew  J. McRiner</span>, <span class="hlFld-ContribAuthor ">Tommi  M. Meulemans</span>, <span class="hlFld-ContribAuthor ">Peter  van Rijnsbergen</span>, <span class="hlFld-ContribAuthor ">Wim  Zonneveld</span>, <span class="hlFld-ContribAuthor ">Duane  A. Burnett</span>. </span><span class="cited-content_cbyCitation_article-title">Strategic and Tactical Approaches to the Synthesis of 5,6-Dihydro-[1,2,4]oxadiazines. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2016,</strong> <em>92 </em>
                                    (12)
                                     , 2166. <a href="https://doi.org/10.3987/COM-16-13570" title="DOI URL">https://doi.org/10.3987/COM-16-13570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-16-13570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-16-13570%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DStrategic%252Band%252BTactical%252BApproaches%252Bto%252Bthe%252BSynthesis%252Bof%252B5%25252C6-Dihydro-%25255B1%25252C2%25252C4%25255Doxadiazines%26aulast%3DJ.%2BN.%2BVeerman%26aufirst%3DJohan%26date%3D2016%26volume%3D92%26issue%3D12%26spage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz  Fernandez</span>, <span class="hlFld-ContribAuthor ">Mark R.J.  Elsegood</span>, <span class="hlFld-ContribAuthor ">Gary  Fairley</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Simon J.  Teat</span>, <span class="hlFld-ContribAuthor ">George W.  Weaver</span>. </span><span class="cited-content_cbyCitation_article-title">Isolation and structure determination of the first example of the azeto[2,3-c]quinolizinedione ring system. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (36)
                                     , 5120-5122. <a href="https://doi.org/10.1016/j.tetlet.2015.07.029" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.07.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.07.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.07.029%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIsolation%252Band%252Bstructure%252Bdetermination%252Bof%252Bthe%252Bfirst%252Bexample%252Bof%252Bthe%252Bazeto%25255B2%25252C3-c%25255Dquinolizinedione%252Bring%252Bsystem%26aulast%3DFernandez%26aufirst%3DBeatriz%26date%3D2015%26volume%3D56%26issue%3D36%26spage%3D5120%26epage%3D5122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Rajesh  Gontla</span>, <span class="hlFld-ContribAuthor ">Leandi  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">Sebastian  Oeck</span>, <span class="hlFld-ContribAuthor ">Julia  Ketzer</span>, <span class="hlFld-ContribAuthor ">Petra  Janning</span>, <span class="hlFld-ContribAuthor ">André  Richters</span>, <span class="hlFld-ContribAuthor ">Thomas  Mühlenberg</span>, <span class="hlFld-ContribAuthor ">Zhizhou  Fang</span>, <span class="hlFld-ContribAuthor ">Abu  Taher</span>, <span class="hlFld-ContribAuthor ">Verena  Jendrossek</span>, <span class="hlFld-ContribAuthor ">Stephen C.  Pelly</span>, <span class="hlFld-ContribAuthor ">Sebastian  Bauer</span>, <span class="hlFld-ContribAuthor ">Willem A. L.  van Otterlo</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Kovalent-allosterische Kinase-Inhibitoren. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (35)
                                     , 10452-10456. <a href="https://doi.org/10.1002/ange.201502142" title="DOI URL">https://doi.org/10.1002/ange.201502142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201502142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201502142%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DKovalent-allosterische%252BKinase-Inhibitoren%26aulast%3DWeisner%26aufirst%3DJ%25C3%25B6rn%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D35%26spage%3D10452%26epage%3D10456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jörn  Weisner</span>, <span class="hlFld-ContribAuthor ">Rajesh  Gontla</span>, <span class="hlFld-ContribAuthor ">Leandi  van der Westhuizen</span>, <span class="hlFld-ContribAuthor ">Sebastian  Oeck</span>, <span class="hlFld-ContribAuthor ">Julia  Ketzer</span>, <span class="hlFld-ContribAuthor ">Petra  Janning</span>, <span class="hlFld-ContribAuthor ">André  Richters</span>, <span class="hlFld-ContribAuthor ">Thomas  Mühlenberg</span>, <span class="hlFld-ContribAuthor ">Zhizhou  Fang</span>, <span class="hlFld-ContribAuthor ">Abu  Taher</span>, <span class="hlFld-ContribAuthor ">Verena  Jendrossek</span>, <span class="hlFld-ContribAuthor ">Stephen C.  Pelly</span>, <span class="hlFld-ContribAuthor ">Sebastian  Bauer</span>, <span class="hlFld-ContribAuthor ">Willem A. L.  van Otterlo</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent-Allosteric Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (35)
                                     , 10313-10316. <a href="https://doi.org/10.1002/anie.201502142" title="DOI URL">https://doi.org/10.1002/anie.201502142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201502142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201502142%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DCovalent-Allosteric%252BKinase%252BInhibitors%26aulast%3DWeisner%26aufirst%3DJ%25C3%25B6rn%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D35%26spage%3D10313%26epage%3D10316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayla  Hazrathoseyni</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Seyedi</span>, <span class="hlFld-ContribAuthor ">Ali  Shiri</span>, <span class="hlFld-ContribAuthor ">Hossein  Eshghi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of [1,2,4]Triazolo[4″,3″:1′,6′]Pyrimido[4′,5′:3,4]Pyridazino[1,6-D] [1,2,4]Triazine; A Novel Tetracyclic System. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2015,</strong> <em>39 </em>
                                    (3)
                                     , 148-153. <a href="https://doi.org/10.3184/174751915X14241706062908" title="DOI URL">https://doi.org/10.3184/174751915X14241706062908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3184/174751915X14241706062908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3184%2F174751915X14241706062908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DSynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B4%2525E2%252580%2525B3%25252C3%2525E2%252580%2525B3%25253A1%2525E2%252580%2525B2%25252C6%2525E2%252580%2525B2%25255DPyrimido%25255B4%2525E2%252580%2525B2%25252C5%2525E2%252580%2525B2%25253A3%25252C4%25255DPyridazino%25255B1%25252C6-D%25255D%252B%25255B1%25252C2%25252C4%25255DTriazine%25253B%252BA%252BNovel%252BTetracyclic%252BSystem%26aulast%3DHazrathoseyni%26aufirst%3DAyla%26date%3D2015%26date%3D2015%26volume%3D39%26issue%3D3%26spage%3D148%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruth  Nussinov</span>, <span class="hlFld-ContribAuthor ">Chung-Jung  Tsai</span>. </span><span class="cited-content_cbyCitation_article-title">The Design of Covalent Allosteric Drugs. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 249-267. <a href="https://doi.org/10.1146/annurev-pharmtox-010814-124401" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010814-124401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010814-124401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010814-124401%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DThe%252BDesign%252Bof%252BCovalent%252BAllosteric%252BDrugs%26aulast%3DNussinov%26aufirst%3DRuth%26date%3D2015%26volume%3D55%26issue%3D1%26spage%3D249%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richa  Goel</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in development of imidazo[1,2-a]pyrazines: synthesis, reactivity and their biological applications. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (12)
                                     , 3525-3555. <a href="https://doi.org/10.1039/C4OB01380H" title="DOI URL">https://doi.org/10.1039/C4OB01380H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB01380H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB01380H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bdevelopment%252Bof%252Bimidazo%25255B1%25252C2-a%25255Dpyrazines%25253A%252Bsynthesis%25252C%252Breactivity%252Band%252Btheir%252Bbiological%252Bapplications%26aulast%3DGoel%26aufirst%3DRicha%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D12%26spage%3D3525%26epage%3D3555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaik  Karamthulla</span>, <span class="hlFld-ContribAuthor ">Md. Nasim  Khan</span>, <span class="hlFld-ContribAuthor ">Lokman H.  Choudhury</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted synthesis of novel 2,3-disubstituted imidazo[1,2-a]pyridines via one-pot three component reactions. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (25)
                                     , 19724-19733. <a href="https://doi.org/10.1039/C4RA16298F" title="DOI URL">https://doi.org/10.1039/C4RA16298F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA16298F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA16298F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave-assisted%252Bsynthesis%252Bof%252Bnovel%252B2%25252C3-disubstituted%252Bimidazo%25255B1%25252C2-a%25255Dpyridines%252Bvia%252Bone-pot%252Bthree%252Bcomponent%252Breactions%26aulast%3DKaramthulla%26aufirst%3DShaik%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D25%26spage%3D19724%26epage%3D19733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Chandrasekhara Rao</span>, <span class="hlFld-ContribAuthor ">N.  Satish Kumar</span>, <span class="hlFld-ContribAuthor ">H. M.  Meshram</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave assisted novel and regioselective functionalization of imidazopyridines with chromene acetals and β-nitrostyrenes. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (87)
                                     , 70949-70957. <a href="https://doi.org/10.1039/C5RA14674G" title="DOI URL">https://doi.org/10.1039/C5RA14674G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA14674G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA14674G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMicrowave%252Bassisted%252Bnovel%252Band%252Bregioselective%252Bfunctionalization%252Bof%252Bimidazopyridines%252Bwith%252Bchromene%252Bacetals%252Band%252B%2525CE%2525B2-nitrostyrenes%26aulast%3DChandrasekhara%2BRao%26aufirst%3DL.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D87%26spage%3D70949%26epage%3D70957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Alan  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-Oriented Synthetic Strategies Applied to Cancer Chemical Biology and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2014,</strong> <em>19 </em>
                                    (11)
                                     , 17221-17255. <a href="https://doi.org/10.3390/molecules191117221" title="DOI URL">https://doi.org/10.3390/molecules191117221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules191117221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules191117221%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiversity-Oriented%252BSynthetic%252BStrategies%252BApplied%252Bto%252BCancer%252BChemical%252BBiology%252Band%252BDrug%252BDiscovery%26aulast%3DCollins%26aufirst%3DIan%26date%3D2014%26date%3D2014%26volume%3D19%26issue%3D11%26spage%3D17221%26epage%3D17255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sujin  Park</span>, <span class="hlFld-ContribAuthor ">Youngeun  Jung</span>, <span class="hlFld-ContribAuthor ">Ikyon  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Diversity-oriented decoration of pyrrolo[1,2-a]pyrazines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (41)
                                     , 7534-7550. <a href="https://doi.org/10.1016/j.tet.2014.08.003" title="DOI URL">https://doi.org/10.1016/j.tet.2014.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DDiversity-oriented%252Bdecoration%252Bof%252Bpyrrolo%25255B1%25252C2-a%25255Dpyrazines%26aulast%3DPark%26aufirst%3DSujin%26date%3D2014%26volume%3D70%26issue%3D41%26spage%3D7534%26epage%3D7550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Aude  Hiebel</span>, <span class="hlFld-ContribAuthor ">Yacoub  Fall</span>, <span class="hlFld-ContribAuthor ">Marie-Christine  Scherrmann</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward Synthesis of Various 2,3-Diarylimidazo[1,2-
              a
              ]pyridines in PEG
              400
              Medium through One-Pot Condensation and C-H Arylation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (21)
                                     , 4643-4650. <a href="https://doi.org/10.1002/ejoc.201402079" title="DOI URL">https://doi.org/10.1002/ejoc.201402079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201402079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201402079%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DStraightforward%252BSynthesis%252Bof%252BVarious%252B2%25252C3-Diarylimidazo%25255B1%25252C2-%252Ba%252B%25255Dpyridines%252Bin%252BPEG%252B400%252BMedium%252Bthrough%252BOne-Pot%252BCondensation%252Band%252BC-H%252BArylation%26aulast%3DHiebel%26aufirst%3DMarie-Aude%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D21%26spage%3D4643%26epage%3D4650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett M.  Johnson</span>, <span class="hlFld-ContribAuthor ">Malcolm P.  Huestis</span>. </span><span class="cited-content_cbyCitation_article-title">Sequential C3 and C5 Direct C-H Arylation of Imidazo[1,2-
              a
              ]pyrazines with (Hetero)aryl Bromides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>2014 </em>
                                    (8)
                                     , 1589-1593. <a href="https://doi.org/10.1002/ejoc.201301802" title="DOI URL">https://doi.org/10.1002/ejoc.201301802</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201301802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201301802%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSequential%252BC3%252Band%252BC5%252BDirect%252BC-H%252BArylation%252Bof%252BImidazo%25255B1%25252C2-%252Ba%252B%25255Dpyrazines%252Bwith%252B%252528Hetero%252529aryl%252BBromides%26aulast%3DJohnson%26aufirst%3DBrett%2BM.%26date%3D2014%26date%3D2014%26volume%3D2014%26issue%3D8%26spage%3D1589%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhu  Zhan</span>, <span class="hlFld-ContribAuthor ">Daqiang  Li</span>, <span class="hlFld-ContribAuthor ">Jinxin  Che</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: Toward the discovery of novel Akt1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>75 </em>, 11-20. <a href="https://doi.org/10.1016/j.ejmech.2014.01.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.01.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.01.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIntegrating%252Bdocking%252Bscores%25252C%252Binteraction%252Bprofiles%252Band%252Bmolecular%252Bdescriptors%252Bto%252Bimprove%252Bthe%252Baccuracy%252Bof%252Bmolecular%252Bdocking%25253A%252BToward%252Bthe%252Bdiscovery%252Bof%252Bnovel%252BAkt1%252Binhibitors%26aulast%3DZhan%26aufirst%3DWenhu%26date%3D2014%26volume%3D75%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Shuang  Han</span>, <span class="hlFld-ContribAuthor ">Jian-Zhong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Insight into the structural mechanism for PKBα allosteric inhibition by molecular dynamics simulations and free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2014,</strong> <em>48 </em>, 36-46. <a href="https://doi.org/10.1016/j.jmgm.2013.12.002" title="DOI URL">https://doi.org/10.1016/j.jmgm.2013.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2013.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DInsight%252Binto%252Bthe%252Bstructural%252Bmechanism%252Bfor%252BPKB%2525CE%2525B1%252Ballosteric%252Binhibition%252Bby%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bfree%252Benergy%252Bcalculations%26aulast%3DChen%26aufirst%3DShi-Feng%26date%3D2014%26volume%3D48%26spage%3D36%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oya Gursoy  Yilmaz</span>, <span class="hlFld-ContribAuthor ">Elif Ozkirimli  Olmez</span>, <span class="hlFld-ContribAuthor ">Kutlu O.  Ulgen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Akt1 allosteric site to identify novel scaffolds through virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2014,</strong> <em>48 </em>, 1-13. <a href="https://doi.org/10.1016/j.compbiolchem.2013.10.005" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2013.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2013.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2013.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DTargeting%252Bthe%252BAkt1%252Ballosteric%252Bsite%252Bto%252Bidentify%252Bnovel%252Bscaffolds%252Bthrough%252Bvirtual%252Bscreening%26aulast%3DYilmaz%26aufirst%3DOya%2BGursoy%26date%3D2014%26volume%3D48%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiuling  Chen</span>, <span class="hlFld-ContribAuthor ">Tieqiao  Chen</span>, <span class="hlFld-ContribAuthor ">Yongbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Daoqing  Han</span>, <span class="hlFld-ContribAuthor ">Li-Biao  Han</span>, <span class="hlFld-ContribAuthor ">Shuang-Feng  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free aerobic oxidative C–N bond cleavage of tertiary amines for the synthesis of N-heterocycles with high atom efficiency. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (23)
                                     , 3802-3807. <a href="https://doi.org/10.1039/C4OB00578C" title="DOI URL">https://doi.org/10.1039/C4OB00578C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00578C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00578C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DMetal-free%252Baerobic%252Boxidative%252BC%2525E2%252580%252593N%252Bbond%252Bcleavage%252Bof%252Btertiary%252Bamines%252Bfor%252Bthe%252Bsynthesis%252Bof%252BN-heterocycles%252Bwith%252Bhigh%252Batom%252Befficiency%26aulast%3DChen%26aufirst%3DXiuling%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D23%26spage%3D3802%26epage%3D3807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiaorong  Han</span>, <span class="hlFld-ContribAuthor ">Yuliang  Jiang</span>, <span class="hlFld-ContribAuthor ">Can  Jin</span>, <span class="hlFld-ContribAuthor ">Shanshan  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiaoxia  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Wang</span>, <span class="hlFld-ContribAuthor ">Bingxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Hyperbranched polyester nanorods with pyrrolo[2,1-a]isoquinoline end groups for fluorescent recognition of Fe
              3+. </span><span class="cited-content_cbyCitation_journal-name">Polym. Chem.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (20)
                                     , 5900-5905. <a href="https://doi.org/10.1039/C4PY00787E" title="DOI URL">https://doi.org/10.1039/C4PY00787E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4PY00787E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4PY00787E%26sid%3Dliteratum%253Aachs%26jtitle%3DPolym.%2520Chem.%26atitle%3DHyperbranched%252Bpolyester%252Bnanorods%252Bwith%252Bpyrrolo%25255B2%25252C1-a%25255Disoquinoline%252Bend%252Bgroups%252Bfor%252Bfluorescent%252Brecognition%252Bof%252BFe%252B3%25252B%26aulast%3DHan%26aufirst%3DQiaorong%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D20%26spage%3D5900%26epage%3D5905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Cun  Tan</span>, <span class="hlFld-ContribAuthor ">Qian  He</span>, <span class="hlFld-ContribAuthor ">Yuyuan  Xie</span>, <span class="hlFld-ContribAuthor ">Chunhao  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A novel convenient approach towards pyrrolo[1,2-b]pyridazines through a domino coupling–isomerization–condensation reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (16)
                                     , 2574. <a href="https://doi.org/10.1039/c3ob40157j" title="DOI URL">https://doi.org/10.1039/c3ob40157j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob40157j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob40157j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Bnovel%252Bconvenient%252Bapproach%252Btowards%252Bpyrrolo%25255B1%25252C2-b%25255Dpyridazines%252Bthrough%252Ba%252Bdomino%252Bcoupling%2525E2%252580%252593isomerization%2525E2%252580%252593condensation%252Breaction%26aulast%3DWang%26aufirst%3DMeng%26date%3D2013%26volume%3D11%26issue%3D16%26spage%3D2574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naveen  Sharma</span>, <span class="hlFld-ContribAuthor ">Edward B.  Arias</span>, <span class="hlFld-ContribAuthor ">Donel A.  Sequea</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Cartee</span>. </span><span class="cited-content_cbyCitation_article-title">Preventing the calorie restriction-induced increase in insulin-stimulated Akt2 phosphorylation eliminates calorie restriction's effect on glucose uptake in skeletal muscle. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</span><span> <strong>2012,</strong> <em>1822 </em>
                                    (11)
                                     , 1735-1740. <a href="https://doi.org/10.1016/j.bbadis.2012.07.012" title="DOI URL">https://doi.org/10.1016/j.bbadis.2012.07.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbadis.2012.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbadis.2012.07.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Basis%2520of%2520Disease%26atitle%3DPreventing%252Bthe%252Bcalorie%252Brestriction-induced%252Bincrease%252Bin%252Binsulin-stimulated%252BAkt2%252Bphosphorylation%252Beliminates%252Bcalorie%252Brestriction%252527s%252Beffect%252Bon%252Bglucose%252Buptake%252Bin%252Bskeletal%252Bmuscle%26aulast%3DSharma%26aufirst%3DNaveen%26date%3D2012%26volume%3D1822%26issue%3D11%26spage%3D1735%26epage%3D1740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Marie</span>, <span class="hlFld-ContribAuthor ">Sébastien  Bouclé</span>, <span class="hlFld-ContribAuthor ">Cécile  Enguehard-Gueiffier</span>, <span class="hlFld-ContribAuthor ">Alain  Gueiffier</span>. </span><span class="cited-content_cbyCitation_article-title">Regiocontrolled Microwave Assisted Bifunctionalization of 7,8-Dihalogenated Imidazo[1,2-a]pyridines: A One Pot Double-Coupling Approach. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2012,</strong> <em>17 </em>
                                    (9)
                                     , 10683-10707. <a href="https://doi.org/10.3390/molecules170910683" title="DOI URL">https://doi.org/10.3390/molecules170910683</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules170910683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules170910683%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRegiocontrolled%252BMicrowave%252BAssisted%252BBifunctionalization%252Bof%252B7%25252C8-Dihalogenated%252BImidazo%25255B1%25252C2-a%25255Dpyridines%25253A%252BA%252BOne%252BPot%252BDouble-Coupling%252BApproach%26aulast%3DMarie%26aufirst%3DEmilie%26date%3D2012%26date%3D2012%26volume%3D17%26issue%3D9%26spage%3D10683%26epage%3D10707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Allosteric inhibitor of inactive AKT, MK-2206 (<b>1</b>), and an example of an inhibitor of active AKT, GDC-0068 (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SAR for allosteric inhibition of AKT based on published data (left panel) and strategy for optimization to give novel cores (right panel).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Reference Compound <b>3</b> and Imidazopyridazine Scaffold <b>5</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetonitrile, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane, 100 °C, 18 h; (ii) tetra-<i>n</i>-butylammonium bromide, 1,3-dibromopropane, toluene, water, 100 °C, 1 h; (iii) KOH, 2,2′-oxidiethanol, 245 °C, 75 min; (iv) DPPA, Et<sub>3</sub>N, dichloromethane, 25 °C, 4 h; (v) aq HCl, 60 °C, 5.5 h; (vi) NH<sub>3</sub>, ethanol, 150 °C, 24 h; (vii) 2-chloroacetaldehyde, H<sub>2</sub>O, 60 °C, 16 h; (viii) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, Pd(PPh<sub>3</sub>)<sub>4</sub>, Zn(OAc)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 100 °C, 1 h, then TFA, dichloromethane, rt, 1 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 6,5-Bridgehead-Based Scaffolds <b>6</b> and <b>7</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) TMS–acetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, tetrahydrofuran, 70 °C, 12 h; (ii) K<sub>2</sub>CO<sub>3</sub>, methanol, rt, 1 h; (iii) LDA, tetrahydrofuran, ClCO<sub>2</sub>Et, −78 °C to rt, 1.5 h; (iv) 1-aminopyridinium iodide, DBU, CH<sub>3</sub>CN, 0 °C to rt, 18 h; (v) NaOH, ethanol, 100 °C, 2 h; (vi) NBS, Na<sub>2</sub>CO<sub>3</sub>, dimethylformamide, rt, 1 h; (vii) phenylboronic acid, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 15 min; (viii) TFA, dichloromethane, rt, 2 h; (ix) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 10 min; (x) NIS, CH<sub>3</sub>CN, rt, 1 h; (xi) phenylboronic acid, aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dimethylformamide, 1,2-dimethoxyethane, ethanol, H<sub>2</sub>O, 150 °C, 15 min; (xii) TFA, dichloromethane, rt, 2 h.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Imidazopyrazine Scaffold <b>11</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, 100 °C, 2 h; (ii) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, aq Na<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 1 h; (iii) 2-chloroacetaldehyde, H<sub>2</sub>O, dimethylformamide, 70 °C, 1.5 h then HCl, dioxane, dichloromethane, rt, 1 h.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Fused South Analogue <b>15</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) 4-bromopyridine-3-carbaldehyde, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 42 h; (ii) MeONH<sub>2</sub>.HCl, Et<sub>3</sub>N, dichloromethane, rt, 5.5 h; (iii) CuCl<sub>2</sub>, DMA, 100 °C, 3.5 h; (iv) phenylboronic acid, Pd(OAc)<sub>2</sub>, potassium orthophosphate, toluene, 80 °C, 2 h; (v) HCl, dioxane, dichloromethane, rt, 15 min.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Pyridine Scaffold <b>26</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Reagents and conditions: (i) <i>tert</i>-butyl <i>N</i>-[1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl]carbamate, 1,1-bis(di-<i>tert</i>-butylphosphino)ferrocene palladium dichloride, aq K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, 18 h; (ii) phenylboronic acid, Pd(OAc)<sub>2</sub>, potassium orthophosphate, toluene, 80 °C, 2 h then HCl, dioxane, dichloromethane, methanol, rt, 3.5 h.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>15</b> docked into AKT based on PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O96">3O96</a>. Trp80 π–π stacks with the aza isoquinoline scaffold, and there is an assumed water-mediated hydrogen bond between the inhibitor primary amine and Asn54.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0012.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Plot of predicted in vivo clearance values versus measured, based on in vitro scaling from rat hepatocyte data for selected compounds. The solid line is a 1:1 correlation and dotted lines represent ±2-fold spread.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0013.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>26</b> on AKT pathway proteins in the BT474c breast adenocarcinoma cell line at 24 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0014.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Pharmacodynamic study of compound <b>26</b> in nude mice bearing a BT474c xenograft from a single oral dose of 100 and 200 mg/kg at 4 and 24 h time points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/medium/jm-2011-01394e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0015.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Tumor growth inhibition study of compound <b>26</b> in BT474c xenografts growing in nude mice. Compound was dosed once a day orally for 21 days at 100 and 200 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm201394e/production/images/large/jm-2011-01394e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201394e&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i56">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J. J.</span><span> </span><span class="NLM_article-title">Targeting the phosphoinositide 3-kinase pathway in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnrd2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19644473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=627-644&author=P.+Liuauthor=H.+Chengauthor=T.+M.+Robertsauthor=J.+J.+Zhao&title=Targeting+the+phosphoinositide+3-kinase+pathway+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the phosphoinositide 3-kinase pathway in cancer</span></div><div class="casAuthors">Liu, Pixu; Cheng, Hailing; Roberts, Thomas M.; Zhao, Jean J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">627-644</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The phosphoinositide 3-kinase (PI3K) pathway is a key signal transduction system that links oncogenes and multiple receptor classes to many essential cellular functions, and is perhaps the most commonly activated signalling pathway in human cancer.  This pathway therefore presents both an opportunity and a challenge for cancer therapy.  Even as inhibitors that target PI3K isoforms and other major nodes in the pathway, including AKT and mammalian target of rapamycin (mTOR), reach clin. trials, major issues remain.  Here, we highlight recent progress that has been made in our understanding of the PI3K pathway and discuss the potential of and challenges for the development of therapeutic agents that target this pathway in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUk9T-ZoNDtLVg90H21EOLACvtfcHk0lj8aQp0M_GWaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1Wgtb4%253D&md5=fdc94abd15178a9dbe7c56dafbfb7787</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2926%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DRoberts%26aufirst%3DT.%2BM.%26aulast%3DZhao%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520the%2520phosphoinositide%25203-kinase%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D627%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Courtney, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span> </span><span class="NLM_article-title">The PI3K pathway as a drug target in human cancer</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1075</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1200%2FJCO.2009.25.3641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20085938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2010&pages=1075-1083&author=K.+D.+Courtneyauthor=B.+Ryanauthor=J.+A.+Engelman&title=The+PI3K+pathway+as+a+drug+target+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The PI3K pathway as drug target in human cancer</span></div><div class="casAuthors">Courtney, Kevin D.; Corcoran, Ryan B.; Engelman, Jeffrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1075-1083</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  The phosphatidylinositol 3-kinase (PI3K) signaling axis impacts on cancer cell growth, survival, motility, and metab.  This pathway is activated by several different mechanisms in cancers, including somatic mutation and amplification of genes encoding key components.  In addn., PI3K signaling may serve integral functions for noncancerous cells in the tumor microenvironment.  Consequently, therapeutics targeting the PI3K pathway are being developed at a rapid pace, and preclin. and early clin. studies are beginning to suggest specific strategies to effectively use them.  However, the central role of PI3K signaling in a large array of diverse biol. processes raises concerns about its use in therapeutics and increases the need to develop sophisticated strategies for its use.  In this review, we will discuss how PI3K signaling affects the growth and survival of tumor cells.  From this vantage, we will consider how inhibitors of the PI3K signaling cascade, either alone or in combination with other therapeutics, can most effectively be used for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpPqtk2bVl0rVg90H21EOLACvtfcHk0lj8aQp0M_GWaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2lt7w%253D&md5=b88b394919647e2eb47e7735355fde2a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1200%2FJCO.2009.25.3641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2009.25.3641%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DRyan%26aufirst%3DB.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520PI3K%2520pathway%2520as%2520a%2520drug%2520target%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2010%26volume%3D28%26spage%3D1075%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Manning, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">Navigating downstream of AKT</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1261-1274&author=B.+D.+Manningauthor=L.+C.+Cantley&title=Navigating+downstream+of+AKT"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DB.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DNavigating%2520downstream%2520of%2520AKT%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D1261%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bozulic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, B. A.</span><span> </span><span class="NLM_article-title">PIKKing on PKB: Regulation of PKB activity by phosphorylation</span> <span class="citation_source-journal">Curr. Opin Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1016%2Fj.ceb.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19303758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=256-261&author=L.+Bozulicauthor=B.+A.+Hemmings&title=PIKKing+on+PKB%3A+Regulation+of+PKB+activity+by+phosphorylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">PIKKing on PKB: regulation of PKB activity by phosphorylation</span></div><div class="casAuthors">Bozulic, Lana; Hemmings, Brian A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">256-261</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B (PKB)/Akt kinase is a key regulator of a wide range of cellular processes including growth, proliferation and survival.  PKB is clearly a crucial signaling mol. and extensive research efforts aim to understand its regulation and action.  Recent studies of the regulation of PKB activity by hydrophobic motif phosphorylation have yielded several exciting findings about members of the phosphatidylinositol 3-kinase (PI3K)-like family of kinases (PIKKs) acting as PKB regulators.  Mammalian target of rapamycin complex 2 (mTORC2) and DNA-dependent protein kinase (DNA-PK) can both phosphorylate Ser-473 and activate PKB.  This review concerns PKB regulation by mTORC2 and DNA-PK in a stimulus-dependent and context-dependent manner and the possible implications of this for PKB activity, substrate specificity, and therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgDTdYbqJWtLVg90H21EOLACvtfcHk0liJFhhuA_-gNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVClu7Y%253D&md5=0b7a3e6ea561f8479701a01133b5d30c</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DBozulic%26aufirst%3DL.%26aulast%3DHemmings%26aufirst%3DB.%2BA.%26atitle%3DPIKKing%2520on%2520PKB%253A%2520Regulation%2520of%2520PKB%2520activity%2520by%2520phosphorylation%26jtitle%3DCurr.%2520Opin%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">1098</span><span class="NLM_x">–</span> <span class="NLM_lpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1126%2Fscience.1106148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=15718470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=1098-1101&author=D.+D.+Sarbassovauthor=D.+A.+Guertinauthor=S.+M.+Aliauthor=D.+M.+Sabatini&title=Phosphorylation+and+regulation+of+Akt%2FPKB+by+the+rictor-mTOR+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex</span></div><div class="casAuthors">Sarbassov, Dos D.; Guertin, David A.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5712</span>),
    <span class="NLM_cas:pages">1098-1101</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Deregulation of Akt/protein kinase B (PKB) is implicated in the pathogenesis of cancer and diabetes.  Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.  We show that in Drosophila and human cells the target of rapamycin (TOR) kinase and its assocd. protein rictor are necessary for Ser473 phosphorylation and that a redn. in rictor or mammalian TOR (mTOR) expression inhibited an Akt/PKB effector.  The rictor-mTOR complex directly phosphorylated Akt/PKB on Ser473 in vitro and facilitated Thr308 phosphorylation by PDK1.  Rictor-mTOR may serve as a drug target in tumors that have lost the expression of PTEN, a tumor suppressor that opposes Akt/PKB activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO1KyVE3glrVg90H21EOLACvtfcHk0liJFhhuA_-gNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSrtbY%253D&md5=de758fd8128561e34301e67a42ae13a6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106148%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DPhosphorylation%2520and%2520regulation%2520of%2520Akt%252FPKB%2520by%2520the%2520rictor-mTOR%2520complex%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D1098%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Pierce, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komander, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The nuts and bolts of AGC protein kinases</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnrm2822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20027184" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=9-22&author=L.+R.+Pierceauthor=D.+Komanderauthor=D.+R.+Alessi&title=The+nuts+and+bolts+of+AGC+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrm2822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2822%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DL.%2BR.%26aulast%3DKomander%26aufirst%3DD.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520nuts%2520and%2520bolts%2520of%2520AGC%2520protein%2520kinases%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2010%26volume%3D11%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mattmann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoops, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Inhibition of Akt with small molecules and biologics: Historical perspective and current status of the patent landscape</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1517%2F13543776.2011.587959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=21635152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1309-1338&issue=9&author=M.+E.+Mattmannauthor=S.+L.+Stoopsauthor=C.+W.+Lindsley&title=Inhibition+of+Akt+with+small+molecules+and+biologics%3A+Historical+perspective+and+current+status+of+the+patent+landscape"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape</span></div><div class="casAuthors">Mattmann, Margrith E.; Stoops, Sydney L.; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1309-1338</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Akt plays a pivotal role in cell survival and proliferation through a no. of downstream effectors; unregulated activation of the PI3K/PTEN/Akt pathway is a prominent feature of many human cancers.  Akt is considered an attractive target for cancer therapy by the inhibition of Akt alone or in combination with std. cancer chemotherapeutics.  Both preclin. animal studies and clin. trials in humans have validated Akt as an important target of cancer drug discovery.Area covered: A historical perspective of Akt inhibitors, including PI analogs, ATP-competitive and allosteric Akt inhibitors, along with other inhibitory mechanisms are reviewed in this paper with a focus on issued patents, patent applications and a summary of clin. trial updates since the last review in 2007.Expert opinion: A vast diversity of inhibitors of Akt, both small mol. and biol., have been developed in the past 5 years, with over a dozen in various phases of clin. development, and several displaying efficacy in humans.  While it is not yet clear which mechanism of Akt inhibition will be optimal in humans, or which Akt isoforms to inhibit, or whether a small mol. or biol. agent will be best, data to all of these points will be available in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByLgyoYrIULVg90H21EOLACvtfcHk0liJFhhuA_-gNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVWnurfM&md5=292eeb3e83a0a8aaa3fea0cb8df7d83d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.587959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.587959%26sid%3Dliteratum%253Aachs%26aulast%3DMattmann%26aufirst%3DM.%2BE.%26aulast%3DStoops%26aufirst%3DS.%2BL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DInhibition%2520of%2520Akt%2520with%2520small%2520molecules%2520and%2520biologics%253A%2520Historical%2520perspective%2520and%2520current%2520status%2520of%2520the%2520patent%2520landscape%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26issue%3D9%26spage%3D1309%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Meuillet, E. J.</span><span> </span><span class="NLM_article-title">Novel inhibitors of AKT: Assessment of a different approach targeting the pleckstrin homology domain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2727</span><span class="NLM_x">–</span> <span class="NLM_lpage">2742</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.2174%2F092986711796011292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=21649580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2727-2742&author=E.+J.+Meuillet&title=Novel+inhibitors+of+AKT%3A+Assessment+of+a+different+approach+targeting+the+pleckstrin+homology+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain</span></div><div class="casAuthors">Meuillet, E. J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2727-2742</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein kinase B/AKT plays a central role in cancer.  The Ser/Thr kinase is over-expressed or constitutively active in many cancers and was validated as a therapeutic target for cancer treatment.  However, targeting the kinase activity has revealed itself to be a challenge due to non-selectivity of the compds. towards other kinases.  This review summarizes other approaches scientists have developed to inhibit the activity and function of AKT.  They consist of targeting the pleckstrin homol. (PH) domain of AKT.  Indeed, upon the generation of 3-phosphorylated phosphatidylinositol phosphates (PI3Ps) by PI3-kinase (PI3K), AKT translocates from the cytosol to the plasma membrane and binds to the PI3Ps via its PH domain.  Thus, several analogs of PI3Ps (PI Analogs or PIAs), alkylphospholipids (APLs), such as edelfosine, and inositol phosphates (IPs) have been described that inhibit the binding of the PH domain to PI3Ps.  Recently allosteric inhibitors and small mols. that do not bind the kinase domain but affect the kinase activity of AKT, presumably by interacting with the PH domain, were also identified.  Finally, several drug screening studies spawned novel chem. scaffolds that bind the PH domain of AKT.  Together, these approaches were more or less successful in vitro and to some extent translated in preclin. studies.  Several of these new AKT PH domain inhibitors exhibit promising anti-tumor activity in mouse models and some of them show synergy with ionizing radiation and chemotherapy.  Early clin. trials have started and results will attest to the validity and efficacy of such approaches in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquNQ7fkejNPbVg90H21EOLACvtfcHk0lhTq1cjx71efg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Cit73O&md5=ff82a5abce3e67670681942e6af0ba19</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F092986711796011292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711796011292%26sid%3Dliteratum%253Aachs%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26atitle%3DNovel%2520inhibitors%2520of%2520AKT%253A%2520Assessment%2520of%2520a%2520different%2520approach%2520targeting%2520the%2520pleckstrin%2520homology%2520domain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2727%26epage%3D2742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Okuzumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiedler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aizenstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Inhibitor hijacking of Akt activation</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">484</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1038%2Fnchembio.183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=19465931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=484-493&author=T.+Okuzumiauthor=D.+Fiedlerauthor=C.+Zhangauthor=D.+C.+Grayauthor=B.+Aizensteinauthor=R.+Hoffmanauthor=K.+M.+Shokat&title=Inhibitor+hijacking+of+Akt+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor hijacking of Akt activation</span></div><div class="casAuthors">Okuzumi, Tatsuya; Fiedler, Dorothea; Zhang, Chao; Gray, Daniel C.; Aizenstein, Brian; Hoffman, Randy; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">484-493</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The kinase Akt plays a central role as a regulator of multiple growth factor input signals, thus making it an attractive anticancer drug target.  A-443654 is an ATP-competitive Akt inhibitor.  Unexpectedly, treatment of cells with A-443654 causes paradoxical hyperphosphorylation of Akt at its two regulatory sites (Thr308 and Ser473).  We explored whether inhibitor-induced hyperphosphorylation of Akt by A-443654 is a consequence of disrupted feedback regulation at a pathway level or whether it is a direct consequence of inhibitor binding to the ATP binding site of Akt.  Catalytically inactive mutants of Akt revealed that binding of an inhibitor to the ATP site of Akt is sufficient to directly cause hyperphosphorylation of the kinase in the absence of any pathway feedback effects.  We conclude that ATP-competitive Akt inhibitors impart regulatory phosphorylation of their target kinase Akt.  These results provide new insights into both natural regulation of Akt activation and Akt inhibitors entering the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWNjUB9YVue7Vg90H21EOLACvtfcHk0lhTq1cjx71efg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlarsrY%253D&md5=4edb5a0457fd9378850102a6414bfdb5</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.183%26sid%3Dliteratum%253Aachs%26aulast%3DOkuzumi%26aufirst%3DT.%26aulast%3DFiedler%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DGray%26aufirst%3DD.%2BC.%26aulast%3DAizenstein%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DR.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DInhibitor%2520hijacking%2520of%2520Akt%2520activation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D484%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Hirai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sootome, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakatsuru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujioka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumder, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, H.</span><span> </span><span class="NLM_article-title">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1956</span><span class="NLM_x">–</span> <span class="NLM_lpage">1967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm201394e&amp;key=10.1158%2F1535-7163.MCT-09-1012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm201394e&amp;key=20571069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=1956-1967&issue=7&author=H.+Hiraiauthor=H.+Sootomeauthor=Y.+Nakatsuruauthor=K.+Miyamaauthor=S.+Taguchiauthor=K.+Tsujiokaauthor=Y.+Uenoauthor=H.+Hatchauthor=P.+K.+Majumderauthor=B.-S.+Panauthor=H.+Kotani&title=MK-2206%2C+an+allosteric+Akt+inhibitor%2C+enhances+antitumor+efficacy+by+standard+chemotherapeutic+agents+or+molecular+targeted+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo</span></div><div class="casAuthors">Hirai, Hiroshi; Sootome, Hiroshi; Nakatsuru, Yoko; Miyama, Katsuyoshi; Taguchi, Shunsuke; Tsujioka, Kyoko; Ueno, Yoko; Hatch, Harold; Majumder, Pradip K.; Pan, Bo-Sheng; Kotani, Hidehito</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1956-1967</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The serine/threonine kinase Akt lies at a crit. signaling node downstream of phosphatidylinositol-3-kinase and is important in promoting cell survival and inhibiting apoptosis.  An Akt inhibitor may be particularly useful for cancers in which increased Akt signaling is assocd. with reduced sensitivity to cytotoxic agents or receptor tyrosine kinase inhibitors.  We evaluated the effect of a novel allosteric Akt inhibitor, MK-2206, in combination with several anticancer agents.  In vitro, MK-2206 synergistically inhibited cell proliferation of human cancer cell lines in combination with mol. targeted agents such as erlotinib (an epidermal growth factor receptor inhibitor) or lapatinib (a dual epidermal growth factor receptor/human epidermal growth factor receptor 2 inhibitor).  Complementary inhibition of erlotinib-insensitive Akt phosphorylation by MK-2206 was one mechanism of synergism, and a synergistic effect was found even in erlotinib-insensitive cell lines.  MK-2206 also showed synergistic responses in combination with cytotoxic agents such as topoisomerase inhibitors (doxorubicin, camptothecin), antimetabolites (gemcitabine, 5-fluorouracil), anti-microtubule agents (docetaxel), and DNA cross-linkers (carboplatin) in lung NCI-H460 or ovarian A2780 tumor cells.  The synergy with docetaxel depended on the treatment sequence; a schedule of MK-2206 dosed before docetaxel was not effective.  MK-2206 suppressed the Akt phosphorylation that is induced by carboplatin and gemcitabine.  In vivo, MK-2206 in combination with these agents exerted significantly more potent tumor inhibitory activities than each agent in the monotherapy setting.  These findings suggest that Akt inhibition may augment the efficacy of existing cancer therapeutics; thus, MK-2206 is a promising agent to treat cancer patients who receive these cytotoxic and/or mol. targeted agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPgnWgk1SeALVg90H21EOLACvtfcHk0lhLqFYJuPm6tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbnL&md5=f2d97ab64963cc82d97b35697e49b172</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-1012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-1012%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DH.%26aulast%3DSootome%26aufirst%3DH.%26aulast%3DNakatsuru%26aufirst%3DY.%26aulast%3DMiyama%26aufirst%3DK.%26aulast%3DTaguchi%26aufirst%3DS.%26aulast%3DTsujioka%26aufirst%3DK.%26aulast%3DUeno%26aufirst%3DY.%26aulast%3DHatch%26aufirst%3DH.%26aulast%3DMajumder%26aufirst%3DP.%2BK.%26aulast%3DPan%26aufirst%3DB.-S.%26aulast%3DKotani%26aufirst%3DH.%26atitle%3DMK-2206%252C%2520an%2520allosteric%2520Akt%2520inhibitor%252C%2520enhances%2520antitumor%2520efficacy%2520by%2520standard%2520chemotherapeutic%2520agents%2520or%2520molecular%2520targeted%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D7%26spage%3D1956%26epage%3D1967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mitchell, I. S.; Blake, J. F.; Xu, R.; Kallan, N. C.; Xiao, D.; Spencer, K. L.; Bencsik, J. R.; Liang, J.; Safina, B.; Zhang, B.; Chabot, C.; Do, S.</span><span> </span><span class="NLM_article-title">Preparation of cyclopenta[<i>d</i>]pyrimidine derivatives as Akt protein kinase inhibitors</span>. PCT Int. Appl. WO2008006040,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+S.+Mitchell&author=J.+F.+Blake&author=R.+Xu&author=N.+C.+Kallan&author=D.+Xiao&author=K.+L.+Spencer&author=J.+R.+Bencsik&author=J.+Liang&author=B.+Safina&author=B.+Zhang&author=C.+Chabot&author=S.+Do&title=Preparation+of+cyclopenta%5Bd%5Dpyrimidine+derivatives+as+Akt+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DI.%2BS.%26atitle%3DPreparation%2520of%2520cyclopenta%255Bd%255Dpyrimidine%2520derivatives%2520as%2520Akt%2520protein%2520kinase%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pal, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reckamp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figlin, R. A.</span><span> </span><span class="NLM_article-title">Akt inhibitors in clinical development for the treatment of cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1366</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=1355-1366&issue=11&author=S.+K.+Palauthor=K.+Reckampauthor=H.+Yuauthor=R.+A.+Figlin&title=Akt+inhibitors+in+clinical+development+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPal%26aufirst%3DS.%2BK.%26aulast%3DReckamp%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26atitle%3DAkt%2520inhibitors%2520in%2520clinical%2520development%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D19%26issue%3D11%26spage%3D1355%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Johnson, P. D.; Leach, A.; Luke, R. W. A.; Matusiak, Z. S.; Morris, J. J.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolo[2,3-<i>d</i>]pyrimidine derivatives as protein kinase B inhibitors</span>. WO2009047563.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johnson%2C+P.+D.%3B+Leach%2C+A.%3B+Luke%2C+R.+W.+A.%3B+Matusiak%2C+Z.+S.%3B+Morris%2C+J.+J.+Preparation+of+pyrrolo%5B2%2C3-d%5Dpyrimidine+derivatives+as+protein+kinase+B+inhibitors.+WO2009047563."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DP.%2BD.%26atitle%3DPreparation%2520of%2520pyrrolo%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520protein%2520kinase%2520B%2520inhibitors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leander, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span> </span><span class="NLM_article-title">Allosteric inhibitors of Akt1 and Akt2: Discovery of [1,2,4]triazolo[3,4-<i>f</i>][1,6]naphthyridines with potent and balanced activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">834</span><span class="NLM_x">–</span> <span class="NLM_lpage">836</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=834-836&issue=3&author=Y.+Liauthor=J.+Liangauthor=T+Siuauthor=E.+Huauthor=M.+A.+Rossiauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=R.+G.+Robinsonauthor=K.+Leanderauthor=H.+E.+Huberauthor=S.+Mittalauthor=N.+Cosfordauthor=P.+Prasit&title=Allosteric+inhibitors+of+Akt1+and+Akt2%3A+Discovery+of+%5B1%2C2%2C4%5Dtriazolo%5B3%2C4-f%5D%5B1%2C6%5Dnaphthyridines+with+potent+and+balanced+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DSiu%26aufirst%3DT%26aulast%3DHu%26aufirst%3DE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DLeander%26aufirst%3DK.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DMittal%26aufirst%3DS.%26aulast%3DCosford%26aufirst%3DN.%26aulast%3DPrasit%26aufirst%3DP.%26atitle%3DAllosteric%2520inhibitors%2520of%2520Akt1%2520and%2520Akt2%253A%2520Discovery%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B3%252C4-f%255D%255B1%252C6%255Dnaphthyridines%2520with%2520potent%2520and%2520balanced%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D834%26epage%3D836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neilson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Development of pyridopyrimidines as potent Akt1/2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1274-1279&issue=4&author=Z.+Wuauthor=J.+C.+Hartnettauthor=L.+A.+Neilsonauthor=R.+G.+Robinsonauthor=S.+Fuauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=A.+M.+Kralauthor=H.+E.+Huberauthor=G.+D.+Hartmanauthor=M.+T.+Bilodeau&title=Development+of+pyridopyrimidines+as+potent+Akt1%2F2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHartnett%26aufirst%3DJ.%2BC.%26aulast%3DNeilson%26aufirst%3DL.%2BA.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DFu%26aufirst%3DS.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DDevelopment%2520of%2520pyridopyrimidines%2520as%2520potent%2520Akt1%252F2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D4%26spage%3D1274%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Allosteric Akt (PKB) inhibitors: Discovery and SAR of isozyme selective inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">761</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=761-764&issue=3&author=C.+W.+Lindsleyauthor=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Duggan&title=Allosteric+Akt+%28PKB%29+inhibitors%3A+Discovery+and+SAR+of+isozyme+selective+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DAllosteric%2520Akt%2520%2528PKB%2529%2520inhibitors%253A%2520Discovery%2520and%2520SAR%2520of%2520isozyme%2520selective%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D3%26spage%3D761%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wu, W.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voegtli, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturgis, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dizon, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J</span><span> </span><span class="NLM_article-title">Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition</span> <span class="citation_source-journal">PLoS ONE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">e12913</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e12913&issue=9&author=W.-I.+Wuauthor=W.+C.+Voegtliauthor=H.+L.+Sturgisauthor=F.+P.+Dizonauthor=G+Vigersauthor=B.+J+Brandhuber&title=Crystal+structure+of+human+AKT1+with+an+allosteric+inhibitor+reveals+a+new+mode+of+kinase+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.-I.%26aulast%3DVoegtli%26aufirst%3DW.%2BC.%26aulast%3DSturgis%26aufirst%3DH.%2BL.%26aulast%3DDizon%26aufirst%3DF.%2BP.%26aulast%3DVigers%26aufirst%3DG%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ%26atitle%3DCrystal%2520structure%2520of%2520human%2520AKT1%2520with%2520an%2520allosteric%2520inhibitor%2520reveals%2520a%2520new%2520mode%2520of%2520kinase%2520inhibition%26jtitle%3DPLoS%2520ONE%26date%3D2010%26volume%3D5%26issue%3D9%26spage%3De12913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cai, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wautlet, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeyaseelan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukral, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamath, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derbin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fargnoli, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhide, R. S.</span><span> </span><span class="NLM_article-title">Discovery of brivanib alaninate ((<i>S</i>)-((<i>R</i>)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-<i>f</i>][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1976</span><span class="NLM_x">–</span> <span class="NLM_lpage">1980</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7013309" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1976-1980&issue=6&author=Z.-W.+Caiauthor=Y.+Zhangauthor=R.+M.+Borzilleriauthor=L.+Qianauthor=S.+Barbosaauthor=D.+Weiauthor=X.+Zhengauthor=L.+Wuauthor=J.+Fanauthor=Z.+Shiauthor=B.+S.+Wautletauthor=S.+Mortilloauthor=R.+Jeyaseelanauthor=D.+W.+Kukralauthor=A.+Kamathauthor=P.+Maratheauthor=C.+D%E2%80%99Arienzoauthor=G.+Derbinauthor=J.+C.+Barrishauthor=J.+A.+Roblauthor=J.+T.+Huntauthor=L.+J.+Lombardoauthor=J.+Fargnoliauthor=R.+S.+Bhide&title=Discovery+of+brivanib+alaninate+%28%28S%29-%28%28R%29-1-%284-%284-fluoro-2-methyl-1H-indol-5-yloxy%29-5-methylpyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazin-6-yloxy%29propan-2-yl%292-aminopropanoate%29%2C+a+novel+prodrug+of+dual+vascular+endothelial+growth+factor+receptor-2+and+fibroblast+growth+factor+receptor-1+kinase+inhibitor+%28BMS-540215%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm7013309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7013309%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DZ.-W.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBorzilleri%26aufirst%3DR.%2BM.%26aulast%3DQian%26aufirst%3DL.%26aulast%3DBarbosa%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DWautlet%26aufirst%3DB.%2BS.%26aulast%3DMortillo%26aufirst%3DS.%26aulast%3DJeyaseelan%26aufirst%3DR.%26aulast%3DKukral%26aufirst%3DD.%2BW.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDerbin%26aufirst%3DG.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DHunt%26aufirst%3DJ.%2BT.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DFargnoli%26aufirst%3DJ.%26aulast%3DBhide%26aufirst%3DR.%2BS.%26atitle%3DDiscovery%2520of%2520brivanib%2520alaninate%2520%2528%2528S%2529-%2528%2528R%2529-1-%25284-%25284-fluoro-2-methyl-1H-indol-5-yloxy%2529-5-methylpyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazin-6-yloxy%2529propan-2-yl%25292-aminopropanoate%2529%252C%2520a%2520novel%2520prodrug%2520of%2520dual%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520and%2520fibroblast%2520growth%2520factor%2520receptor-1%2520kinase%2520inhibitor%2520%2528BMS-540215%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D6%26spage%3D1976%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hoelder, S.; Zuelch, A.; Baer, T.; Maier, T.; Zimmermann, A.; Beckers, T.; Gekeler, V.; Joshi, H.; Munot, Y.; Bhise, U.; Chavan, S.; Shivatare, S.; Patel, S.; Gore, V.</span><span> </span><span class="NLM_article-title">Preparation of fused imidazoles for cancer treatment</span>. PCT Int. Appl. WO2009021990,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=S.+Hoelder&author=A.+Zuelch&author=T.+Baer&author=T.+Maier&author=A.+Zimmermann&author=T.+Beckers&author=V.+Gekeler&author=H.+Joshi&author=Y.+Munot&author=U.+Bhise&author=S.+Chavan&author=S.+Shivatare&author=S.+Patel&author=V.+Gore&title=Preparation+of+fused+imidazoles+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DPreparation%2520of%2520fused%2520imidazoles%2520for%2520cancer%2520treatment%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leister, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C. W.</span><span> </span><span class="NLM_article-title">Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=905-909&issue=4&author=Z.+Zhaoauthor=W.+H.+Leisterauthor=R.+G.+Robinsonauthor=S.+F.+Barnettauthor=D.+Defeo-Jonesauthor=R.+E.+Jonesauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=H.+E.+Huberauthor=M.+E.+Dugganauthor=C.+W.+Lindsley&title=Discovery+of+2%2C3%2C5-trisubstituted+pyridine+derivatives+as+potent+Akt1+and+Akt2+dual+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DLeister%26aufirst%3DW.%2BH.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%25202%252C3%252C5-trisubstituted%2520pyridine%2520derivatives%2520as%2520potent%2520Akt1%2520and%2520Akt2%2520dual%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26issue%3D4%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Synthesis of functionalized isoquinolines via sequential cyclization/cross-coupling reactions</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/doi/10.1021/cc900079s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm201394e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWktb3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=895-899&issue=5&author=X.+Yuauthor=J.+Wu&title=Synthesis+of+functionalized+isoquinolines+via+sequential+cyclization%2Fcross-coupling+reactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Functionalized Isoquinolines via Sequential Cyclization/Cross-Coupling Reactions</span></div><div class="casAuthors">Yu, Xingxin; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">895-899</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">CuX2-mediated cyclization of 2-alkynylbenzaldehyde O-Me oximes in N,N-dimethylacetamide (DMA) gave rise to 4-chloroisoquinolines, e.g. I (X = Cl), in good yield, which underwent the palladium-catalyzed cross-coupling reactions of arylboronic acids subsequently to afford the functionalized isoquinolines, e.g. I (X = Ph).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOetzxg_l4prVg90H21EOLACvtfcHk0ljWC8NN18E3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWktb3E&md5=95382c64c669dff9a9b9945224b2bc91</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcc900079s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc900079s%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520functionalized%2520isoquinolines%2520via%2520sequential%2520cyclization%252Fcross-coupling%2520reactions%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26issue%3D5%26spage%3D895%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hartnett, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Defeo-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span> </span><span class="NLM_article-title">Optimization of 2,3,5-trisubstituted pyridine derivatives as potent allosteric Akt1 and Akt2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2194</span><span class="NLM_x">–</span> <span class="NLM_lpage">2197</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2194-2197&issue=6&author=J.+C.+Hartnettauthor=S.+F.+Barnettauthor=M.+T.+Bilodeauauthor=D.+Defeo-Jonesauthor=G.+D.+Hartmanauthor=H.+E.+Huberauthor=R.+E.+Jonesauthor=A.+M.+Kralauthor=R.+G.+Robinsonauthor=Z.+Wu&title=Optimization+of+2%2C3%2C5-trisubstituted+pyridine+derivatives+as+potent+allosteric+Akt1+and+Akt2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHartnett%26aufirst%3DJ.%2BC.%26aulast%3DBarnett%26aufirst%3DS.%2BF.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DDefeo-Jones%26aufirst%3DD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuber%26aufirst%3DH.%2BE.%26aulast%3DJones%26aufirst%3DR.%2BE.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DRobinson%26aufirst%3DR.%2BG.%26aulast%3DWu%26aufirst%3DZ.%26atitle%3DOptimization%2520of%25202%252C3%252C5-trisubstituted%2520pyridine%2520derivatives%2520as%2520potent%2520allosteric%2520Akt1%2520and%2520Akt2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D6%26spage%3D2194%26epage%3D2197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>Maestro, version 9.2; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+version+9.2%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>Glide, version 5.7; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.7%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sohlenius-Sternbeck, A.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afzelius, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoogstraate, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floby, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bengtsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gissberg, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sternbeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersson, C.</span><span> </span><span class="NLM_article-title">Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">637</span><span class="NLM_x">–</span> <span class="NLM_lpage">649</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=637-649&author=A.-K.+Sohlenius-Sternbeckauthor=L.+Afzeliusauthor=P.+Prusisauthor=J.+Neelissenauthor=J.+Hoogstraateauthor=J.+Johanssonauthor=E.+Flobyauthor=A.+Bengtssonauthor=O.+Gissbergauthor=J.+Sternbeckauthor=C.+Petersson&title=Evaluation+of+the+human+prediction+of+clearance+from+hepatocyte+and+microsome+intrinsic+clearance+for+52+drug+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSohlenius-Sternbeck%26aufirst%3DA.-K.%26aulast%3DAfzelius%26aufirst%3DL.%26aulast%3DPrusis%26aufirst%3DP.%26aulast%3DNeelissen%26aufirst%3DJ.%26aulast%3DHoogstraate%26aufirst%3DJ.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DFloby%26aufirst%3DE.%26aulast%3DBengtsson%26aufirst%3DA.%26aulast%3DGissberg%26aufirst%3DO.%26aulast%3DSternbeck%26aufirst%3DJ.%26aulast%3DPetersson%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520the%2520human%2520prediction%2520of%2520clearance%2520from%2520hepatocyte%2520and%2520microsome%2520intrinsic%2520clearance%2520for%252052%2520drug%2520compounds%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D637%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ashwell, M. A.; Brassard, C.; Filikov, A.; Hill, J.; Koerner, S.; Lapierre, J.-M.; Liu, Y.; Namdev, N.; Nicewonger, R.; Palma, R.; Tandon, M.; Vensel, D.; Matsuda, A.; Iimura, S.; Yamamoto, Y.</span><span> </span><span class="NLM_article-title">Preparation of substituted imidazopyridinyl-aminopyridine compounds as antitumor agents</span>. PCT Int. Appl. WO2011082270,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+A.+Ashwell&author=C.+Brassard&author=A.+Filikov&author=J.+Hill&author=S.+Koerner&author=J.-M.+Lapierre&author=Y.+Liu&author=N.+Namdev&author=R.+Nicewonger&author=R.+Palma&author=M.+Tandon&author=D.+Vensel&author=A.+Matsuda&author=S.+Iimura&author=Y.+Yamamoto&title=Preparation+of+substituted+imidazopyridinyl-aminopyridine+compounds+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshwell%26aufirst%3DM.%2BA.%26atitle%3DPreparation%2520of%2520substituted%2520imidazopyridinyl-aminopyridine%2520compounds%2520as%2520antitumor%2520agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bell, M. P.; O’Dowd, C. R.; Rountree, J. S. S.; Trevitt, G. P.; Harrison, T.; McFarland, M. M..</span><span> </span><span class="NLM_article-title">Preparation of furopyrimidine and furopyridine derivatives as AKT/PKB inhibitors</span>. PCT Int. Appl. WO2011055115,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+P.+Bell&author=C.+R.+O%E2%80%99Dowd&author=J.+S.+S.+Rountree&author=G.+P.+Trevitt&author=T.+Harrison&author=M.+M..+McFarland&title=Preparation+of+furopyrimidine+and+furopyridine+derivatives+as+AKT%2FPKB+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%2520furopyrimidine%2520and%2520furopyridine%2520derivatives%2520as%2520AKT%252FPKB%2520inhibitors%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bell, M. P.; O’Dowd, C. R.; Zhang, L.; Tevitt, G. P.; Harrison, T.; Battacharyya, S.; Rountree, J. S. S.; Burkamp, F.; Price, S.; Macleod, C.; Elliott, R. L.; Smith, P.; Blench, T. J.; Dyke, H. J.</span><span> </span><span class="NLM_article-title">Preparation of chromen-4-one, pyrano[2,3-<i>c</i>]pyridin-4-one, and 7<i>H</i>-pyrano[2,3-<i>e</i>]indazol-4-one derivatives as anticancer agents</span>. PCT Int. Appl.  WO2011033265,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+P.+Bell&author=C.+R.+O%E2%80%99Dowd&author=L.+Zhang&author=G.+P.+Tevitt&author=T.+Harrison&author=S.+Battacharyya&author=J.+S.+S.+Rountree&author=F.+Burkamp&author=S.+Price&author=C.+Macleod&author=R.+L.+Elliott&author=P.+Smith&author=T.+J.+Blench&author=H.+J.+Dyke&title=Preparation+of+chromen-4-one%2C+pyrano%5B2%2C3-c%5Dpyridin-4-one%2C+and+7H-pyrano%5B2%2C3-e%5Dindazol-4-one+derivatives+as+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DM.%2BP.%26atitle%3DPreparation%2520of%2520chromen-4-one%252C%2520pyrano%255B2%252C3-c%255Dpyridin-4-one%252C%2520and%25207H-pyrano%255B2%252C3-e%255Dindazol-4-one%2520derivatives%2520as%2520anticancer%2520agents%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O96','PDB','3O96'); return false;">PDB: 3O96</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/jm201394e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_30086"></div></div></div></div></div><hr /></hr><p class="last">Details of the full synthesis and spectroscopic characterization of all additional compounds and intermediates, in addition to all protocols for in vitro and in vivo experiments. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201394e/suppl_file/jm201394e_si_001.pdf">jm201394e_si_001.pdf (267.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201394e&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm201394e%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201394e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998200af022290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
